<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">64744</article-id><article-id pub-id-type="doi">10.7554/eLife.64744</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Tools and Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>An in vivo reporter for tracking lipid droplet dynamics in transparent zebrafish</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-215762"><name><surname>Lumaquin</surname><given-names>Dianne</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5285-0467</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-215763"><name><surname>Johns</surname><given-names>Eleanor</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6802-041X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215765"><name><surname>Montal</surname><given-names>Emily</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215764"><name><surname>Weiss</surname><given-names>Joshua M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-7340-4004</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-237415"><name><surname>Ola</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215767"><name><surname>Abuhashem</surname><given-names>Abderhman</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-20435"><name><surname>White</surname><given-names>Richard M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9099-9169</contrib-id><email>whiter@mskcc.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund11"/><xref ref-type="other" rid="fund12"/><xref ref-type="other" rid="fund13"/><xref ref-type="other" rid="fund14"/><xref ref-type="other" rid="fund15"/><xref ref-type="other" rid="fund16"/><xref ref-type="other" rid="fund17"/><xref ref-type="other" rid="fund18"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution>Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center</institution><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program</institution><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Gerstner Sloan Kettering Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center</institution><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Developmental Biology Program, Memorial Sloan Kettering Cancer Center</institution><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Schlegel</surname><given-names>Amnon</given-names></name><role>Reviewing Editor</role><aff><institution>University of Utah School of Medicine</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Stainier</surname><given-names>Didier YR</given-names></name><role>Senior Editor</role><aff><institution>Max Planck Institute for Heart and Lung Research</institution><country>Germany</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>11</day><month>06</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e64744</elocation-id><history><date date-type="received" iso-8601-date="2020-11-09"><day>09</day><month>11</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-05-14"><day>14</day><month>05</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Lumaquin et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Lumaquin et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-64744-v1.pdf"/><abstract><p>Lipid droplets are lipid storage organelles found in nearly all cell types from adipocytes to cancer cells. Although increasingly implicated in disease, current methods to study lipid droplets in vertebrate models rely on static imaging or the use of fluorescent dyes, limiting investigation of their rapid in vivo dynamics. To address this, we created a lipid droplet transgenic reporter in whole animals and cell culture by fusing tdTOMATO to Perilipin-2 (PLIN2), a lipid droplet structural protein. Expression of this transgene in transparent <italic>casper</italic> zebrafish enabled in vivo imaging of adipose depots responsive to nutrient deprivation and high-fat diet. Simultaneously, we performed a large-scale in vitro chemical screen of 1280 compounds and identified several novel regulators of lipolysis in adipocytes. Using our <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> zebrafish line, we validated several of these novel regulators and revealed an unexpected role for nitric oxide in modulating adipocyte lipid droplets. Similarly, we expressed the PLIN2-tdTOMATO transgene in melanoma cells and found that the nitric oxide pathway also regulated lipid droplets in cancer. This model offers a tractable imaging platform to study lipid droplets across cell types and disease contexts using chemical, dietary, or genetic perturbations.</p></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p>Organisms need fat molecules as a source of energy and as building blocks, but these ‘lipids’ can also damage cells if they are present in large amounts. Cells guard against such toxicity by safely sequestering lipids in specialized droplets that participate in a range of biological processes. For instance, these structures can quickly change size to store or release lipids depending on the energy demands of a cell.</p><p>It is possible to image lipid droplets – using, for example, dyes that preferentially stain fat – but often these methods can only yield a snapshot: tracking lipid droplet dynamics over time remains difficult. Lumaquin, Johns et al. therefore set out to develop a new method that could label lipid droplets and monitor their behaviour ‘live’ in the cells of small, transparent zebrafish larvae.</p><p>First, the fish were genetically manipulated so that a key protein found in lipid droplets would carry a fluorescent tag: this made the structures strongly fluorescent and easy to track over time. And indeed, Lumaquin, Johns et al. could monitor changes in the droplets depending on the fish diet, with the structures getting bigger when the animal received rich food, and shrinking when resources were scarce. Finally, experiments were conducted to screen for compounds that could lead to lipids being released in fat cells. The new imaging technique was then used to confirm the effect of these molecules in live cells, revealing an unexpected role for a signalling molecule known as nitric oxide, which also turned out to be regulating lipid droplets in cancerous cells. Further work then showed that drugs affecting nitric oxide could modulate lipid droplet size in both normal and tumor cells.</p><p>This work has validated a new method to study the real-time behavior of lipid droplets and their responses to different stimuli in living cells. In the future, Lumaquin, Johns et al. hope that the technique will help to shed new light on how lipids are involved in both healthy and abnormal biological processes.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>adipocyte</kwd><kwd>obesity</kwd><kwd>lipid droplet</kwd><kwd>cancer metabolism</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>F30 CA254152</award-id><principal-award-recipient><name><surname>Lumaquin</surname><given-names>Dianne</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>T32GM007739-42</award-id><principal-award-recipient><name><surname>Lumaquin</surname><given-names>Dianne</given-names></name><name><surname>Weiss</surname><given-names>Joshua M</given-names></name><name><surname>Abuhashem</surname><given-names>Abderhman</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>5K00CA223016-04</award-id><principal-award-recipient><name><surname>Montal</surname><given-names>Emily</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>F30 HD 103398</award-id><principal-award-recipient><name><surname>Abuhashem</surname><given-names>Abderhman</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>F31 AR079215</award-id><principal-award-recipient><name><surname>Johns</surname><given-names>Eleanor</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R25CA020449</award-id><principal-award-recipient><name><surname>Ola</surname><given-names>David</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100005190</institution-id><institution>Melanoma Research Alliance</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>White</surname><given-names>Richard M</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01CA229215</award-id><principal-award-recipient><name><surname>White</surname><given-names>Richard M</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01CA238317</award-id><principal-award-recipient><name><surname>White</surname><given-names>Richard M</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>DP2CA186572</award-id><principal-award-recipient><name><surname>White</surname><given-names>Richard M</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010304</institution-id><institution>Pershing Square Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>White</surname><given-names>Richard M</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100014599</institution-id><institution>Mark Foundation For Cancer Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>White</surname><given-names>Richard M</given-names></name></principal-award-recipient></award-group><award-group id="fund13"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100005976</institution-id><institution>Harry J. Lloyd Charitable Trust</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>White</surname><given-names>Richard M</given-names></name></principal-award-recipient></award-group><award-group id="fund14"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>P30 CA008748</award-id><principal-award-recipient><name><surname>White</surname><given-names>Richard M</given-names></name></principal-award-recipient></award-group><award-group id="fund15"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007052</institution-id><institution>Memorial Sloan-Kettering Cancer Center</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>White</surname><given-names>Richard M</given-names></name></principal-award-recipient></award-group><award-group id="fund16"><funding-source><institution-wrap><institution>Consano</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>White</surname><given-names>Richard M</given-names></name></principal-award-recipient></award-group><award-group id="fund17"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006205</institution-id><institution>SSC</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>White</surname><given-names>Richard M</given-names></name></principal-award-recipient></award-group><award-group id="fund18"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000048</institution-id><institution>American Cancer Society</institution></institution-wrap></funding-source><award-id>American Cancer Society Research Scholar</award-id><principal-award-recipient><name><surname>White</surname><given-names>Richard M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A novel transgenic lipid droplet reporter in transparent <italic>casper</italic> zebrafish allows direct visualization of individual lipid droplets in a living animal.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Lipid droplets are cellular organelles that act as storage sites for neutral lipids and are key regulators of cellular metabolism (<xref ref-type="bibr" rid="bib77">Wilfling et al., 2013</xref>). Lipid droplets are present in most cell types and are characterized by a monophospholipid membrane surrounding a hydrophobic lipid core (<xref ref-type="bibr" rid="bib69">Tauchi-Sato et al., 2002</xref>; <xref ref-type="bibr" rid="bib77">Wilfling et al., 2013</xref>). Cells maintain energetic homeostasis and membrane formation through the regulated incorporation and release of fatty acids and lipid species from the lipid droplet core (<xref ref-type="bibr" rid="bib37">Kurat et al., 2009</xref>; <xref ref-type="bibr" rid="bib35">Kuerschner et al., 2008</xref>; <xref ref-type="bibr" rid="bib24">Fujimoto et al., 2007</xref>; <xref ref-type="bibr" rid="bib83">Zimmermann et al., 2004</xref>). Importantly, lipid droplets can assume various functions during cellular stress through the sequestration of potentially toxic lipids and misfolded proteins (<xref ref-type="bibr" rid="bib2">Bailey et al., 2015</xref>; <xref ref-type="bibr" rid="bib42">Listenberger et al., 2003</xref>; <xref ref-type="bibr" rid="bib73">Vevea et al., 2015</xref>; <xref ref-type="bibr" rid="bib22">Fei et al., 2009</xref>), maintenance of energy and redox homeostasis (<xref ref-type="bibr" rid="bib45">Liu et al., 2015</xref>; <xref ref-type="bibr" rid="bib46">Liu et al., 2017</xref>), regulation of fatty acid transfer to the mitochondria for β-oxidation (<xref ref-type="bibr" rid="bib61">Rambold et al., 2015</xref>; <xref ref-type="bibr" rid="bib31">Herms et al., 2015</xref>), and the maintenance of endoplasmic reticulum (ER) membrane homeostasis (<xref ref-type="bibr" rid="bib16">Chitraju et al., 2017</xref>; <xref ref-type="bibr" rid="bib11">Bosma et al., 2014</xref>; <xref ref-type="bibr" rid="bib71">Velázquez et al., 2016</xref>; <xref ref-type="bibr" rid="bib73">Vevea et al., 2015</xref>). Moreover, a recent study demonstrated that lipid droplets actively participate in the innate immune response (<xref ref-type="bibr" rid="bib10">Bosch et al., 2020</xref>) and, conversely, can be hijacked by infectious agents like hepatitis C virus to facilitate viral replication (<xref ref-type="bibr" rid="bib4">Barba et al., 1997</xref>; <xref ref-type="bibr" rid="bib52">Miyanari et al., 2007</xref>; <xref ref-type="bibr" rid="bib74">Vieyres et al., 2020</xref>). The role of lipid droplets in metabolic homeostasis and cellular stress is critical across multiple cell types and has also been increasingly implicated in cancer. For example, lipid droplets can act as a storage pool in cancer cells after they take up lipids from extracellular sources, including adipocytes (<xref ref-type="bibr" rid="bib36">Kuniyoshi et al., 2019</xref>; <xref ref-type="bibr" rid="bib55">Nieman et al., 2011</xref>; <xref ref-type="bibr" rid="bib82">Zhang et al., 2018</xref>).</p><p>Lipid droplets are ubiquitous across most cell types; however, they are essential to the function of adipocytes in regulating organismal energy homeostasis (<xref ref-type="bibr" rid="bib83">Zimmermann et al., 2004</xref>; <xref ref-type="bibr" rid="bib7">Bergman et al., 2001</xref>). White adipocytes, which contain a large unilocular lipid droplet, can be readily labeled by lipophilic dyes (<xref ref-type="bibr" rid="bib50">Minchin and Rawls, 2017a</xref>; <xref ref-type="bibr" rid="bib20">Fam et al., 2018</xref>). However, in vivo imaging of lipid droplets, in adipocytes or other cell types, is currently highly limited. Understanding the dynamics of lipid droplets in vivo, rather than in fixed tissues, is important since the size of the lipid droplet can change very rapidly in response to fluctuating metabolic needs (<xref ref-type="bibr" rid="bib10">Bosch et al., 2020</xref>; <xref ref-type="bibr" rid="bib20">Fam et al., 2018</xref>). In mice, much of adipose tissue imaging utilizes tissue fixation and sectioning, which can fail to preserve key aspects of the tissue structure (<xref ref-type="bibr" rid="bib8">Berry et al., 2014</xref>; <xref ref-type="bibr" rid="bib79">Xue et al., 2010</xref>). Whole-mount imaging approaches in mice can be combined with adipocyte-specific promoters; however, these methods still require tissue dissection and can be limited by tissue thickness (<xref ref-type="bibr" rid="bib9">Berry and Rodeheffer, 2013</xref>; <xref ref-type="bibr" rid="bib15">Chi et al., 2018</xref>).</p><p>Zebrafish offer a tractable model to address these limitations given the ease of high-throughput imaging of live animals. This is especially true with the availability of relatively transparent strains such as <italic>casper</italic>, which allows for detailed in vivo imaging without the need for fixation of the animal (<xref ref-type="bibr" rid="bib76">White et al., 2008</xref>). Although less well studied than other vertebrates, zebrafish adipose tissue is highly similar to mammalian white adipose tissue, and a detailed work has classified the timing, dynamics, and location of zebrafish adipose tissue development (<xref ref-type="bibr" rid="bib50">Minchin and Rawls, 2017a</xref>). Current imaging approaches using lipophilic fluorescent dyes or analogs in vivo have advanced our understanding of lipid droplets in adipocytes and other cell types (<xref ref-type="bibr" rid="bib50">Minchin and Rawls, 2017a</xref>; <xref ref-type="bibr" rid="bib49">Minchin et al., 2018</xref>; <xref ref-type="bibr" rid="bib51">Minchin and Rawls, 2017b</xref>; <xref ref-type="bibr" rid="bib14">Carten et al., 2011</xref>; <xref ref-type="bibr" rid="bib21">Farber et al., 2001</xref>; <xref ref-type="bibr" rid="bib58">Otis and Farber, 2016</xref>); however, these methods can require extensive and repeated staining, which may restrict the ability to read out dynamic changes over time. Furthermore, fluorescent dyes such as BODIPY and NileRed have limitations in their specificity for the lipid droplet (<xref ref-type="bibr" rid="bib18">Daemen et al., 2016</xref>). Finally, although a probe-free imaging approach to study subcellular lipid populations has been recently described (<xref ref-type="bibr" rid="bib32">Høgset et al., 2020</xref>), this method is restricted to early-stage zebrafish, which would fail to capture post-embryonic cell populations and tissues, including adipocytes.</p><p>Here, we report the development of an in vivo lipid droplet reporter using a <italic>-3.5ubb:plin2-tdTomato</italic> transgene in the <italic>casper</italic> strain. To date, transgenic lipid droplet reporters have been restricted to cell culture systems and invertebrate model organisms such as <italic>Caenorhabditis elegans</italic> (<italic>C. elegans</italic>) and <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib68">Targett-Adams et al., 2003</xref>; <xref ref-type="bibr" rid="bib5">Beller et al., 2010</xref>; <xref ref-type="bibr" rid="bib44">Liu et al., 2014</xref>; <xref ref-type="bibr" rid="bib45">Liu et al., 2015</xref>) although a similar approach in zebrafish was recently described while this manuscript was in review (<xref ref-type="bibr" rid="bib78">Wilson et al., 2021</xref>). We demonstrate that the <italic>-3.5ubb:plin2-tdTomato</italic> reporter faithfully marks the lipid droplet, which enables robust in vivo imaging. We show that this reporter can be applied to visualize adipocytes and to monitor adipose tissue remodeling in response to dietary and pharmacologic perturbations. Furthermore, we report the discovery of novel pharmacologic regulators of adipocyte lipolysis such as nitric oxide and demonstrate that several of these compounds can modulate adipose tissue area in our in vivo system. To facilitate the study of lipid droplets in novel contexts outside of adipocytes, we also generated a zebrafish melanoma cell line (ZMEL) (<xref ref-type="bibr" rid="bib28">Heilmann et al., 2015</xref>) expressing <italic>-3.5ubb:plin2-tdTomato</italic> (ZMEL-LD). We confirm that this cell line can be used to monitor changes in lipid droplet production in response to both known and novel regulators of lipolysis. We anticipate that these models will be highly valuable as a high-throughput imaging platform to investigate lipid droplets in both adipose tissue biology and disease contexts such as cancer.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>An in vivo lipid droplet reporter using a PLIN2-tdTOMATO fusion transgene</title><p>To create a specific fluorescent reporter for lipid droplets in zebrafish, we fused <italic>tdTomato</italic> to the 3’ end of the <italic>plin2</italic> cDNA. We chose <italic>plin2</italic> because it is a well-known lipid droplet-associated protein that is ubiquitously expressed on lipid droplets across cell types (<xref ref-type="bibr" rid="bib57">Olzmann and Carvalho, 2019</xref>). We generated stable transgenic zebrafish expressing <italic>-3.5ubb:plin2-tdTomato</italic> and sought to validate whether the construct faithfully marks lipid droplets (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). White adipocytes are fat cells known for their large unilocular lipid droplet (<xref ref-type="bibr" rid="bib26">Fujimoto and Parton, 2011</xref>; <xref ref-type="bibr" rid="bib27">Heid et al., 2014</xref>), so we expected expression of the PLIN2-tdTOMATO fusion protein on the surface of the adipocyte lipid droplet (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Since the adipocyte lipid droplet occupies the majority of space in the cell (<xref ref-type="bibr" rid="bib25">Fujimoto et al., 2020</xref>), existing methods to visualize zebrafish adipocytes rely on lipophilic dyes and lipid analogs, which incorporate into the lipid droplet (<xref ref-type="bibr" rid="bib82">Zhang et al., 2018</xref>). Thus, in addition to labeling individual lipid droplets, we reasoned that the PLIN2-tdTOMATO fusion protein can also function as a reporter for adipocytes since these cells would have the largest and unilocular lipid droplets.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>An in vivo lipid droplet reporter using a PLIN2-tdTOMATO fusion transgene.</title><p>(<bold>A</bold>) Schematic of <italic>ubb:plin2-tdTomato</italic> construct injected into zebrafish and an adipocyte lipid droplet labeled with PLIN2-tdTOMATO fusion protein. Widefield microscope images of adult (<bold>B</bold>) wild-type sibling and (<bold>C</bold>) <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> zebrafish. Box shows zoomed images of the fish tail with panels for brightfield, BODIPY, PLIN2-tdTOMATO, and merge. (<bold>D</bold>) Confocal images of fish tail adipocytes of adult wild-type sibling and <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> zebrafish. Panels show brightfield, BODIPY, PLIN2-tdTOMATO, and merge. (<bold>E</bold>) Adult <italic>casper</italic> and <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> zebrafish tails were fixed and immunohistochemistry was conducted for tdTOMATO expression of tail adipocytes.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64744-fig1-v1.tif"/></fig><p>In adult zebrafish, subcutaneous adipocytes are known to reside proximally to the tail fin (<xref ref-type="bibr" rid="bib50">Minchin and Rawls, 2017a</xref>). When we imaged 6-month-old adult <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> zebrafish, we detected PLIN2-tdTOMATO expression in the zebrafish tail fin adipocytes, which colocalized with BODIPY staining (<xref ref-type="fig" rid="fig1">Figure 1B,C</xref>). Lipophilic dyes such as BODIPY stain the lipid-rich core of the lipid droplet while lipid droplet resident proteins, such as PLIN2, localize to the lipid droplet membrane (<xref ref-type="bibr" rid="bib82">Zhang et al., 2018</xref>). As expected, higher magnification images of tail adipocytes revealed that PLIN2-tdTOMATO expression was on the outside of the lipid droplet, whereas the BODIPY staining was on the interior of each droplet in the adipocyte (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Similarly, immunohistochemistry (IHC) on the <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> zebrafish tail fin showed that adipocytes express tdTOMATO (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Taken together, this data demonstrates that the PLIN2-tdTOMATO fusion protein functions as a fluorescent lipid droplet reporter that can be applied to visualize adipocytes in vivo.</p></sec><sec id="s2-2"><title>The <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> is an in vivo reporter for visceral adipocytes</title><p>Visceral adipose tissue, otherwise known as abdominal fat, plays an important role in metabolism and participates in pathological processes of obesity, aging, and metabolic syndromes (<xref ref-type="bibr" rid="bib70">Tchernof and Després, 2013</xref>). Because PLIN2-tdTOMATO labeled subcutaneous adipocytes in the adult zebrafish tail fin, we wondered whether we could use the <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> zebrafish to visualize other adipose depots in vivo such as visceral adipocytes. In 21 days post-fertilization (dpf) zebrafish, visceral adipose tissue is composed of abdominal and pancreatic visceral adipocytes predominantly located on the right flank near the swim bladder (<xref ref-type="fig" rid="fig2">Figure 2A</xref>; <xref ref-type="bibr" rid="bib50">Minchin and Rawls, 2017a</xref>). To determine whether <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> visceral adipocytes express PLIN2-tdTOMATO, we imaged around the swim bladder of zebrafish where we expected development of abdominal visceral adipocytes (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Visceral adipocytes visualized in brightfield demonstrate colocalization of PLIN2-tdTOMATO and BODIPY, as we observed for subcutaneous adipocytes (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). IHC confirmed that the abdominal and visceral adipocytes of <italic>Tg(-3.5ubb:plin2-Tomato)</italic> express tdTOMATO (<xref ref-type="fig" rid="fig2">Figure 2G</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>Tg(-3.5ubb:plin2-tdTomato)</italic> is an in vivo reporter for visceral adipocytes.</title><p>(<bold>A</bold>) Schematic of visceral adipose tissue development in the 21 days post-fertilization (dpf) zebrafish. Abdominal visceral adipocytes (orange) develop around the swim bladder (gray) and pancreatic visceral adipocytes (red) develop ventrally around the pancreas. (<bold>B</bold>) Brightfield image of <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> at 21 dpf. Red box indicates position of higher magnification images to visualize abdominal visceral adipocytes. (<bold>C</bold>) Widefield microscope images of 21 dpf wild-type <italic>casper</italic> and <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> visceral adipocytes around the posterior swim bladder (SB) costained with BODIPY. Panels show brightfield, BODIPY, tdTOMATO, and merge. BODIPY stained adipose tissue was imaged and analyzed for (<bold>D</bold>) area, (<bold>E</bold>) standard length, and (<bold>F</bold>) area/standard length. Points indicate individual fish for N = 3 independent experiments; wild-type sibling, Data values for (<bold>D-F</bold>). n=35; <italic>Tg(-3.5ubb:plin2-tdTomato)</italic>, n = 28. Bars indicate mean and SEM. Significance calculated via Mann-Whitney test. (<bold>G</bold>) 21 dpf wild-type<italic>casper</italic>and<italic>Tg(-3.5ubb:plin2-tdTomato)</italic>zebrafish were fixed and immunohistochemistry conducted for tdTOMATO expression of abdominal (AVA) and pancreatic visceral adipocytes (PVA).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Data values for <xref ref-type="fig" rid="fig2">Figure 2D-F</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64744-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64744-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Adipose tissue development in wild-type and <italic>Tg(-3.5ubb-plin2-tdTomato)</italic> zebrafish.</title><p>(<bold>A</bold>) Heatmap of adipose depot presence during zebrafish development in <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> and wild-type siblings. Shown is the percent of fish scored for presence of the depot using either BODIPY GFP signal or tdTOMATO expression at each time point. (<bold>B</bold>) Representative whole-mount images demonstrating the timing of adipose tissue development in <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> and wild-type siblings using visceral adipose tissue as an example. Data points are an average of N = 3 independent experiments for each time point, excluding 14 days post-fertilization (dpf), where N = 4, and the adults, where N = 5 (5 dpf WT n = 32, 5 dpf <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> n = 38, 14 dpf WT n = 32, 14 dpf <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> n = 48, 21 dpf WT n = 30, 21 dpf <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> n = 40, 42 dpf WT n = 48, 42 dpf <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> n = 43, adult WT n = 38, adult <italic>Tg(-3.5ubb:plin2-tdTomato</italic>) n = 29).</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Data values for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64744-fig2-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64744-fig2-figsupp1-v1.tif"/></fig></fig-group><p>Previous studies have shown that overexpression of perilipin proteins alters lipid accumulation in adipocytes (<xref ref-type="bibr" rid="bib62">Sawada et al., 2010</xref>). To test whether constitutive expression of our PLIN2-tdTOMATO transgenes altered adiposity, we compared the visceral adipose tissue of <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> fish to their wild-type siblings. Using BODIPY staining, we did not detect differences in visceral adipose tissue area (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). In addition to dpf, standard length can indicate developmental progress in zebrafish (<xref ref-type="bibr" rid="bib60">Parichy et al., 2009</xref>). Similarly, we found no difference in standard lengths between wild-type siblings and <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> at 21 dpf (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). We normalized visceral adipose tissue area to standard length, similar to a Body Mass Index (BMI) in mammals, and did not detect differences between wild-type and <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> fish (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). To comprehensively assess whether constitutive PLIN2-tdTOMATO expression alters adiposity, we imaged adipose depots of wild-type and <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> zebrafish from 5 dpf larvae to adult fish. Using BODIPY staining to visualize adipose tissue, we observed similar development of the major adipose depots between wild-type and <italic>Tg(-3.5:ubbplin2-tdTomato)</italic> zebrafish (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–B</xref>). Furthermore, we detected PLIN2-tdTOMATO expression at the corresponding time points and adipose depots within <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–B</xref>). Thus, the <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> zebrafish faithfully recapitulates normal adipose tissue development.</p></sec><sec id="s2-3"><title>Diet and pharmacologically induced reduction in visceral adipose tissue area</title><p>After confirming that we could image visceral adipose tissue in <italic>Tg(-3.5ubb:plin2-tdTomato)</italic>, we wanted to test whether this could be a tractable platform to image adipose tissue remodeling. We first verified whether we could use <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> to track reduction in visceral adiposity. Fasting is a well-known mechanism for reducing adiposity, since it will induce lipolysis and lead to a reduction in the size of the adipocyte lipid droplet (<xref ref-type="bibr" rid="bib30">Henne et al., 2018</xref>; <xref ref-type="bibr" rid="bib47">Longo and Mattson, 2014</xref>; <xref ref-type="bibr" rid="bib61">Rambold et al., 2015</xref>; <xref ref-type="bibr" rid="bib67">Tang et al., 2017</xref>). To test this, wild-type and <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> zebrafish were fed or fasted for 7 days and then imaged to measure standard length and adipose tissue area (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). As expected, we observed a reduction in the BODIPY-stained visceral adipose tissue in both wild-type and <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> fasted zebrafish (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Similarly, we measured a significant reduction in adipose tissue area, standard length, and normalized area to standard length between fed and fasted fish (<xref ref-type="fig" rid="fig3">Figure 3C,D,E</xref>). Furthermore, we did not see differences in adiposity or standard length between wild-type and <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> fish within the same diet (<xref ref-type="fig" rid="fig3">Figure 3C,D,E</xref>). This suggests that the transgenic expression of PLIN2-tdTOMATO reflects adipose tissue remodeling consistent with wild-type fish.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Fasting reduces visceral adipose tissue area.</title><p>(<bold>A</bold>) Schematic of experimental set-up for fasting experiment. 21 days post-fertilization (dpf) wild-type <italic>casper</italic> and <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> zebrafish were fed or fasted for 7 days and imaged to measure standard length and adipose area. (<bold>B</bold>) Representative images of zebrafish fed or fasted after 7 days. Panels show merged images of brightfield and BODIPY-stained visceral adipose tissue. BODIPY-stained adipocytes were imaged to measure (<bold>C</bold>) area, (<bold>D</bold>) standard length, and (<bold>E</bold>) area/standard length. Data points indicate individual fish for N = 3 independent experiments; bars indicate mean and 95% CI. Fed wild-type n = 24; fed <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> n = 24; fasted wild-type n = 29; fasted <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> n = 20. Significance calculated via Kruskal-Wallis with Dunn’s multiple comparisons test; ****p&lt;0.0001. (<bold>F</bold>) Representative image of computational segmentation of <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> adipocytes. PLIN2-tdTOMATO was background subtracted with GFP fluorescence. Bottom panels show brightfield, segmented adipocytes, and segmentation overlaid on brightfield. (<bold>G</bold>) Schematic of experimental set-up for repeated imaging of 21 dpf <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> zebrafish, which were fed or fasted for 7 days. Adipose tissue was imaged and analyzed for (<bold>H</bold>) area, (<bold>I</bold>) standard length, and (<bold>J</bold>) area/standard length. Points indicate mean and error bars indicate 95% CI for N = 3 independent experiments; by day 7, fed n = 46 and fasted n = 57. Significance calculated via Mann-Whitney test; **p&lt;0.01, ****p&lt;0.0001.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Data values for <xref ref-type="fig" rid="fig3">Figure 3C-E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64744-fig3-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Data values for <xref ref-type="fig" rid="fig3">Figure 3H-J</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64744-fig3-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64744-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Forskolin reduces visceral adipose tissue area.</title><p>(<bold>A</bold>) Schematic of experimental set-up for Forskolin drug treatment. 21 days post-fertilization (dpf) <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> zebrafish were individually placed in six-well plates with either dimethyl sulfoxide (DMSO) or 5 µM Forskolin for 24 hr. Adipose tissue was imaged and analyzed for (<bold>B</bold>) area, (<bold>C</bold>) standard length, and (<bold>D</bold>) area/standard length. Points indicate individual fish for N = 5 independent experiments; DMSO, n = 53; Forskolin, n = 55. Bars indicate mean and SEM. Significance calculated via Mann-Whitney test; *p&lt;0.05.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Data values for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B-D</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64744-fig3-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64744-fig3-figsupp1-v1.tif"/></fig></fig-group><p>Combined with the capacity for high-throughput in vivo imaging in zebrafish, we sought to use <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> as a model to study lipid droplet dynamics in visceral adipocytes. One challenge we encountered was the autofluorescence from the zebrafish intestinal loops and gallbladder present in the tdTOMATO and GFP channels (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). To remove background fluorescence, we developed an image analysis pipeline in MATLAB to segment the visceral adipocytes in juvenile <italic>Tg(-3.5ubb:plin2-Tomato)</italic> zebrafish (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). Next, we combined our image analysis pipeline with the ability to do repeated imaging in zebrafish to more granularly quantify adipose tissue remodeling in fed or fasted <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> fish (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). We saw the expected increase in adipose tissue area, standard length, and normalized area to standard length over 7 days in fed <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> fish (<xref ref-type="fig" rid="fig3">Figure 3H–J</xref>). The standard lengths for fasted fish were significantly lower than those for fed fish and remained stable over 7 days, which we attribute to food restriction, disrupting zebrafish development (<xref ref-type="fig" rid="fig3">Figure 3I</xref>). Notably, we found that visceral adiposity was not reduced until after 2 days of fasting (<xref ref-type="fig" rid="fig3">Figure 3H,J</xref>).</p><p>In addition to fasting as a dietary perturbation, we also pharmacologically reduced adipose tissue. To achieve this, we used Forskolin, a drug that is known to induce lipolysis through cAMP signaling (<xref ref-type="bibr" rid="bib43">Litosch et al., 1982</xref>). We treated juvenile zebrafish for 24 hr with either dimethyl sulfoxide (DMSO) or 5 µM Forskolin and imaged the adipocytes (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). We detected a reduction in both the adipose tissue area and normalized area to standard length in the Forskolin-treated fish, but no differences in standard length (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B–D</xref>). Thus, <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> can be used as an in vivo model to visualize adipocytes, with the benefits of avoiding staining steps and allowing for repeated imaging with high-throughput image analysis in zebrafish.</p></sec><sec id="s2-4"><title>High-fat diet leads to specific enlargement of visceral adipose tissue</title><p>Having shown that we could use <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> to image and measure reduction in adipose tissue, we tested whether we can use our model to detect an increase in adiposity. Zebrafish have been used as a model for diet-induced obesity and share pathophysiological perturbations seen in mammals, but few studies have focused on architectural changes of visceral adipose tissue (<xref ref-type="bibr" rid="bib17">Chu et al., 2012</xref>; <xref ref-type="bibr" rid="bib39">Landgraf et al., 2017</xref>; <xref ref-type="bibr" rid="bib56">Oka et al., 2010</xref>). We sought to determine if we could detect increases in visceral adiposity from a high-fat diet (HFD). We fed juvenile zebrafish with either control feed (12% crude fat) or HFD (23% crude fat) for 7 days and subsequently imaged the adipose tissue (<xref ref-type="fig" rid="fig4">Figure 4A,B</xref>). After a week of HFD feeding, we observed that HFD-fed fish developed significantly increased visceral adiposity compared to the fish fed with control feed (<xref ref-type="fig" rid="fig4">Figure 4C,E</xref>). Although less dramatic between 7 and 14 days of HFD, we found that significantly greater visceral adiposity persisted after 2 weeks of HFD (<xref ref-type="fig" rid="fig4">Figure 4C,E</xref>). Interestingly, we did not detect differences in the standard lengths of the control and HFD-fed fish, suggesting that this formulation of HFD leads to specific enlargement of visceral adipose tissue (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Our results demonstrate that <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> is an effective and unique tool to visualize visceral adipose tissue remodeling induced by HFD, which can be widely applied to study obesity.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>High-fat diet leads to specific enlargement of visceral adipose tissue.</title><p>(<bold>A</bold>) Percent breakdown of nutritional content for control feed and high-fat diet (HFD). (<bold>B</bold>) Schematic of experimental set-up for HFD experiment. 21 days post-fertiization (dpf) <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> zebrafish were fed control feed or HFD for 14 days and imaged to measure standard length and adipose area. Image analysis pipeline resulted in measurements of adipose tissue (<bold>C</bold>) area, (<bold>D</bold>) standard length, and (<bold>E</bold>) area/standard length. Points indicate mean and error bars indicate 95% CI for N = 3 independent experiments; by day 14, control feed n = 57; HFD n = 61. Significance calculated via Mann-Whitney test; *p&lt;0.05, **p&lt;0.01, ****p&lt;0.0001.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Data values for <xref ref-type="fig" rid="fig4">Figure 4A-E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64744-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64744-fig4-v1.tif"/></fig></sec><sec id="s2-5"><title>A screen to discover novel compounds that modulate lipolysis and lipid droplets in vivo</title><p>To meet fluctuating nutritional needs of the cell, lipid droplets are remodeled through lipolysis to regulate lipid mobilization and metabolic homeostasis (<xref ref-type="bibr" rid="bib34">Krahmer et al., 2013</xref>; <xref ref-type="bibr" rid="bib57">Olzmann and Carvalho, 2019</xref>; <xref ref-type="bibr" rid="bib59">Paar et al., 2012</xref>). As a major lipid depot for the body, white adipose tissue is critical to lipid availability and cycles through lipolytic flux in response to energy demands (<xref ref-type="bibr" rid="bib19">Duncan et al., 2007</xref>). In disease contexts such as cancer, adipocytes undergoing lipolysis act as a lipid source for neighboring cancer cells (<xref ref-type="bibr" rid="bib41">Lengyel et al., 2018</xref>). Adipocyte-derived lipids have been directly shown to promote cancer progression in ovarian (<xref ref-type="bibr" rid="bib55">Nieman et al., 2011</xref>), breast (<xref ref-type="bibr" rid="bib3">Balaban et al., 2017</xref>), and melanoma cancer cells (<xref ref-type="bibr" rid="bib82">Zhang et al., 2018</xref>). Due to growing evidence of adipocyte and cancer cell cross-talk as a metabolic adaptation for tumor progression, there is significant interest in disrupting lipid transfer between adipocytes and cancer cells.</p><p>Leveraging our model to visualize lipid droplets in adipocytes, we became interested in identifying novel compounds that remodel adipocyte lipid droplets through lipolysis. In mammalian systems, the most commonly used cell line to study lipolysis is 3T3-L1 cells, which can be differentiated in vitro to resemble adipocytes (<xref ref-type="bibr" rid="bib81">Zebisch et al., 2012</xref>). We first used the 3T3-L1 system to rapidly identify lipolysis inhibitors at high throughput and then test those hits using our zebrafish lipid droplet reporter. We reasoned that compounds that inhibit lipolysis in vitro would cause an increase in the size of the lipid droplets in vivo. To achieve this, we differentiated mouse 3T3-L1 fibroblast cells into adipocytes and conducted a chemical screen for compounds that inhibit lipolysis (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), measured by quantifying glycerol in the media, a gold standard readout of lipolysis in this system (<xref ref-type="bibr" rid="bib29">Hellmér et al., 1989</xref>). As a positive control, we used Atglistatin, an inhibitor of adipose triglyceride lipase (ATGL) that is known to be the rate-limiting step of lipolysis and has been shown to inhibit lipolysis in cell lines and mouse models (<xref ref-type="bibr" rid="bib48">Mayer et al., 2013</xref>; <xref ref-type="bibr" rid="bib64">Schweiger et al., 2017</xref>). We confirmed that Atglistatin potently inhibits lipolysis in 3T3-L1 adipocytes (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). We then screened through a library of 1280 compounds of diverse chemical structures to find novel inhibitors of lipolysis. Overall, we found 29 out of 1280 compounds that led to at least a 40% reduction in lipolysis as measured by glycerol release into the media. Looking more closely at the top 10 hits from this screen, we noted that 2 of the top 10 hits (Auranofin and JS-K) modulated nitric oxide (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Nitric oxide can be used for post-translational modification of proteins via S-nitrosylation (<xref ref-type="bibr" rid="bib66">Stamler et al., 2001</xref>). A previous study has shown that increased nitric oxide has a suppressive role on lipolysis, and Auranofin, a thioredoxin reductase inhibitor that promotes S-nitrosylation, can inhibit lipolysis in 3T3-L1 cells (<xref ref-type="bibr" rid="bib80">Yamada et al., 2015</xref>). Similarly, JS-K is a nitric oxide donor purported to promote S-nitrosylation, but it has not been shown to play a role in lipolysis (<xref ref-type="bibr" rid="bib53">Nath et al., 2010</xref>; <xref ref-type="bibr" rid="bib65">Shami et al., 2003</xref>). Given that both of these top hits were in the same pathway, we chose these for in vivo validation.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>A screen to discover novel compounds that modulate lipolysis and lipid droplets in vivo.</title><p>(<bold>A</bold>) Schematic of pharmacologic lipolysis screen in 3T3-L1 adipocytes using a glycerol release assay. Normalized log<sub>2</sub> transformed values for top 10 drugs that inhibit lipolysis are shown. Magenta indicates compounds that modulate nitric oxide. (<bold>B</bold>) Normalized log<sub>2</sub> transformed values for lipolysis inhibition in 3T3-L1 adipocytes using either dimethyl sulfoxide (DMSO) or 100 µM Atglistatin. N = 5 independent experiments. Bars indicate mean and SEM. Significance calculated via Welch’s t-test; ****p&lt;0.0001. (<bold>C</bold>) Schematic of experimental set-up for drug treatment. 21 days post-fertilization (dpf) <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> zebrafish were individually placed in six-well plates with either DMSO, 40 µM Atglistatin, 1 µM Auranofin, or 1 µM JS-K for 24 hr. Adipose tissue was imaged and analyzed for (<bold>C</bold>) area, (<bold>D</bold>) standard length, and (<bold>E</bold>) area/standard length. Data points indicate individual fish for N = 4 independent experiments; DMSO n = 47; Atglistatin n = 44; Auranofin n = 42; JS-K n = 44. Bars indicate mean and SEM. Significance calculated via Kruskal-Wallis with Dunn’s multiple comparisons test; *p&lt;0.05, ****p&lt;0.0001.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Complete list of lipolysis screen compounds and log2 transformed values.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64744-fig5-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Data values for <xref ref-type="fig" rid="fig5">Figure 5B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64744-fig5-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata3"><label>Figure 5—source data 3.</label><caption><title>Data values for <xref ref-type="fig" rid="fig5">Figure 5C-E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64744-fig5-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64744-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Atglistatin, Auranofin, and JS-K in vivo dose titration.</title><p>Viability of 21 days post-fertilization (dpf) <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> zebrafish was measured after 24 hr of treatment with dimethyl sulfoxide (DMSO) or increasing concentrations of (<bold>A</bold>) Atglistatin, (<bold>B</bold>) Auranofin, or (<bold>C</bold>) JS-K. Percent larval viability measured from N = 3 independent experiments. After 24 hr of drug treatment, 21 dpf zebrafish were imaged to measure (<bold>D</bold>) area, (<bold>E</bold>) standard length, and (<bold>F</bold>) area/standard length. Data points indicate individual fish for N = 5 independent experiments; DMSO n = 29; 1 µM n = 32; 10 µM n = 28; 40 µM n = 31. Bars indicate mean and SEM. Significance calculated via Kruskal-Wallis with Dunn’s multiple comparisons test; *p&lt;0.05.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Data values for <xref ref-type="fig" rid="fig5s1">Figure 3—figure supplement 1A-F</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64744-fig5-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64744-fig5-figsupp1-v1.tif"/></fig></fig-group><p>Next, we asked whether these drugs could modulate lipid droplet size and lead to increased adiposity in zebrafish. We first established the maximal tolerated doses of Atglistatin, Auranofin, and JS-K in vivo (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A–C</xref>), and then tested their effects on adipose tissue in the <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> fish (<xref ref-type="fig" rid="fig5">Figure 5D–F</xref>). As expected, treatment of juvenile zebrafish for 24 hr with Atglistatin caused a significant increase in adipose tissue area without affecting standard length or fish viability at the maximally tolerated dose. Consistent with our screen results, we found that JS-K also significantly increased adiposity (<xref ref-type="fig" rid="fig5">Figure 5C,E</xref>). These effects were specific to the adipose tissue as standard length was not affected (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). These data indicate that modulators of nitric oxide can inhibit lipolysis in cell lines and lead to increased adiposity in vivo in zebrafish. Moreover, this approach demonstrates the power of this system to dissect the relationship between novel modulators of lipolysis (i.e., nitric oxide) and adiposity in vivo.</p></sec><sec id="s2-6"><title>Lipolysis modulators also inhibit lipid droplet loss in melanoma cells</title><p>Upon uptake of adipocyte-derived lipids, cancer cells can store excess lipids in lipid droplets (<xref ref-type="bibr" rid="bib41">Lengyel et al., 2018</xref>). Accumulation of lipid droplets in melanoma cells has been associated with increased metastatic potential and worse clinical outcomes (<xref ref-type="bibr" rid="bib25">Fujimoto et al., 2020</xref>; <xref ref-type="bibr" rid="bib82">Zhang et al., 2018</xref>). The mechanisms regulating subsequent lipolysis from the lipid droplets in cancer cells are not well understood, but we reasoned that some of the same mechanisms (i.e., ATGL, nitric oxide) used in adipocytes might also be used in cancer cells. To test this, we created a stable zebrafish melanoma cell line (ZMEL) that expressed the <italic>-3.5ubb:plin2-tdTomato</italic> construct (<xref ref-type="bibr" rid="bib28">Heilmann et al., 2015</xref>) to generate the ZMEL-LD (lipid droplet) reporter cell line (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Because melanoma cells at baseline only have few small lipid droplets, we induced their formation via extrinsic addition of oleic acid, a key fatty acid that can be transferred from the adipocyte to the melanoma cell (<xref ref-type="bibr" rid="bib82">Zhang et al., 2018</xref>). We found that after a pulse of oleic acid for 24 hr, we could easily detect PLIN2-tdTOMATO expression surrounding lipid droplets marked by the lipid droplet dye Monodansylpentane (MDH) (<xref ref-type="fig" rid="fig6">Figure 6B</xref>, <xref ref-type="video" rid="video1">Video 1</xref>), similar to what we saw in the adipocytes (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Similar to what we did in the whole fish, we wanted to be sure that the PLIN2-tdTOMATO transgene itself did not alter lipid droplets, so we compared lipid droplet formation in ZMEL-LD and parental cell line (ZMEL-GFP) via imaging and flow cytometry (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A,B</xref>). Using the lipid droplet dye Lipidtox as a proxy for lipid droplet content, we pulsed the cells with increasing amounts of oleic acid and found no difference in Lipidtox median fluorescence intensity (MFI) between the two cell lines (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>), indicating that the transgene was not having any unexpected effect. Next, we assessed the sensitivity of the PLIN2-tdTOMATO transgene versus Lipidtox in reporting changes in lipid droplets of ZMEL-LD. While both PLIN2-tdTOMATO and Lipidtox expression increased accordingly with oleic acid, PLIN2-tdTOMATO expression provided a much greater dynamic range (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C–F</xref>), highlighting its advantages over standard lipid dyes like Lipidtox.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Lipolysis modulators also inhibit lipid droplet loss in melanoma cells.</title><p>(<bold>A</bold>) Schematic of zebrafish melanoma cell line with lipid droplet reporter (ZMEL-LD) with lipid droplet labeled by PLIN2-tdTOMATO. (<bold>B</bold>) Confocal images of ZMEL-LD cells after 24 hr of oleic acid treatment. Panels show fluorescence signals in PLIN2-tdTOMATO, MDH (lipid droplet dye) staining, and merge of images with cytoplasmic GFP. Red box indicates position of higher magnification image of lipid droplets. (<bold>C</bold>) ZMEL-LD cells were treated with either bovine serum albumin (BSA) or oleic acid with dimethyl sulfoxide (DMSO) for 72 hr and then analyzed by Fluorescence Activated Cell Sorting (FACS) for PLIN2-tdTOMATO expression. (<bold>D</bold>) Representative histogram of PLIN2-tdTOMATO expression of ZMEL-GFP and GFP+ZMEL-LD cells with indicated drugs. Dashed line shows threshold for PLIN2-tdTOMATO expression. (<bold>E</bold>) Quantification of percent of GFP+ZMEL-LD cells with lipid droplets. Lipid droplet low and high controls were ZMEL-LD cells treated with BSA or oleic acid for 72 hr. For drug treatments, ZMEL-LD cells were pulsed with oleic acid for 24 hr and then given DMSO, 40 µM Atglistatin, 0.5 µM Auranofin, or 0.5 µM JS-K for 48 hr. N = 3 independent experiments. Bars indicate mean and SEM. Significance calculated via one-way ANOVA with Dunnett’s multiple comparisons test; *p&lt;0.05, ***p&lt;0.001, ****p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64744-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Lipid droplet production is equivalent between ZMEL-GFP and ZMEL-LD.</title><p>(<bold>A</bold>) Confocal images of ZMEL-GFP and ZMEL-LD after 24 hr of 150 µM oleic acid treatment. Cells were fixed and stained, with panels showing fluorescence signals for PLIN2-tdTOMATO, Lipidtox (lipid droplet dye), and merge of images with cytoplasmic GFP. ZMEL-GFP and ZMEL-LD cells were treated with bovine serum albumin (BSA) or increasing concentrations of oleic acid for 24 hr and then analyzed by FACS. (<bold>B</bold>) Comparison of Lipidtox median fluorescence intensity (MFI) between ZMEL-GFP and ZMEL-LD. Significance calculated via Welch’s t-test with Bonferroni correction. (<bold>C</bold>) Representative histogram of PLIN2-tdTOMATO expression of ZMEL-GFP and ZMEL-LD cells. Dashed line shows the threshold for PLIN2-tdTOMATO expression. (<bold>D</bold>) Quantification of percent of GFP+ ZMEL-LD cells with lipid droplets. Significance calculated via one-way ANOVA with Dunnett’s multiple comparison test. (<bold>E</bold>) Representative histogram of Lipidtox expression of ZMEL-LD cells. (<bold>F</bold>) Quantification of Lipidtox MFI relative to BSA control of GFP+ZMEL-LD cells. Significance calculated via one-way ANOVA with Dunnett’s multiple comparison test. N = 3 independent experiments. Bars indicate mean and SEM. *p&lt;0.05, **p&lt;0.01, ****p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64744-fig6-figsupp1-v1.tif"/></fig></fig-group><media id="video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-64744-video1.mp4"><label>Video 1.</label><caption><title>3D reconstruction of ZMEL-LD lipid droplet.</title><p>ZMEL-LD cells were given oleic acid for 24 hr, fixed, and stained with the lipid droplet dye MDH. This video is a 3D reconstruction of 37 planes covering a 6 µm stack of a lipid droplet cluster in a ZMEL-LD cell. PLIN2-tdTOMATO (orange) is located outside of the lipid droplet core (blue).</p></caption></media><p>To validate whether the lipolysis-inhibiting compounds we identified above could modulate lipid droplets in ZMEL-LD cells, we utilized the same flow cytometry assay to measure PLIN2-tdTOMATO expression. We treated ZMEL-LD cells for 72 hr with either BSA or oleic acid as controls for low- or high-lipid droplet cell populations (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). We then tested the effects of the lipolysis inhibitors Atglistatin, Auranofin, and JS-K. We pulsed the ZMEL-LD cells with oleic acid for 24 hr (to induce lipid droplets) and then measured the subsequent decay in signal over the ensuing 48 hr, which is expected to decrease due to gradual lipolysis of the lipid droplets. Compared to cells with oleic acid pulse and DMSO, cells given JS-K did not differ in the percent of lipid droplet-positive cells (<xref ref-type="fig" rid="fig6">Figure 6D,E</xref>). In contrast, cells treated with Atglistatin and Auranofin demonstrated significantly higher lipid droplet-positive cells (<xref ref-type="fig" rid="fig6">Figure 6D,E</xref>). These data indicate that similar to adipocytes, ATGL is a key regulatory step in lipolysis in melanoma cells. Moreover, we found that nitric oxide, which was identified in our adipocyte screen, is similarly a modulator of lipolysis in the melanoma context and can be utilized for future studies to target adipocyte-melanoma cell cross-talk. We do not yet understand why different nitric oxide donors are more or less potent in adipocytes (where JS-K is a better inhibitor in vivo) versus melanoma cells (where Auranofin is a better inhibitor), but this could reflect differences in pharmacokinetics or cell-type-specific lipid droplet regulation.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Lipid droplets are cytosolic storage organelles for cellular lipids, which are dynamically regulated in response to metabolic and oxidative perturbations (<xref ref-type="bibr" rid="bib33">Jarc and Petan, 2019</xref>). Changes in the lipid droplet content of a cell can occur in response to a variety of factors, including hypoxia, reactive oxygen stress, ER stress, and alterations in nutrient availability (<xref ref-type="bibr" rid="bib2">Bailey et al., 2015</xref>; <xref ref-type="bibr" rid="bib6">Bensaad et al., 2014</xref>; <xref ref-type="bibr" rid="bib16">Chitraju et al., 2017</xref>; <xref ref-type="bibr" rid="bib71">Velázquez et al., 2016</xref>; <xref ref-type="bibr" rid="bib73">Vevea et al., 2015</xref>; <xref ref-type="bibr" rid="bib13">Cabodevilla et al., 2013</xref>; <xref ref-type="bibr" rid="bib54">Nguyen et al., 2017</xref>). However, the regulatory mechanisms driving these processes remain incompletely understood. Furthermore, lipid droplets are highly heterogeneous, and the pathways that regulate lipid droplet dynamics in specific cell types warrant investigation.</p><p>To address such questions, we report the first lipid droplet reporter in a vertebrate model organism. We show that our <italic>plin2-tdtomato</italic> reporter faithfully marks the lipid droplet in vivo. As a further validation of our approach, while our manuscript was in review, a similar approach using knockin at the endogenous <italic>plin2</italic> promoter was recently described (<xref ref-type="bibr" rid="bib78">Wilson et al., 2021</xref>). The combination of our reporter with the in vivo system of the <italic>casper</italic> zebrafish enables flexible and robust imaging approaches to examine lipid droplet regulation and function. In particular, the ease of chemical and genetic manipulation of the zebrafish combined with high-throughput imaging approaches enables interrogation of relevant pathways in a cell type-specific manner. Furthermore, the capacity for intravital imaging creates the opportunity to conduct longitudinal analysis of lipid droplet dynamics across developmental time and in disease contexts between single animals.</p><p>Here, we demonstrate the capabilities of the <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> line by taking advantage of the fact that white adipocytes are readily labeled by PLIN2-tdTOMATO expression. This labeling enables the study of individual adipocytes and adipose tissue in adult and juvenile zebrafish. We show that the <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> reporter can be used as an alternative to lipophilic fluorescent dyes to study adipose tissue across zebrafish developmental stages while preserving normal adipose tissue development.</p><p>We establish the utility of this transgenic line to study the regulation of adipose tissue by both diet and pharmacologic perturbations. We focused on visceral adipose tissue due to its role as an endocrine organ and the central regulator of organismal metabolism (<xref ref-type="bibr" rid="bib23">Fox et al., 2007</xref>; <xref ref-type="bibr" rid="bib40">Le Jemtel et al., 2018</xref>; <xref ref-type="bibr" rid="bib72">Verboven et al., 2018</xref>). We show that our <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> line is sensitive enough to capture quantitative changes in visceral adipose tissue after short-term pharmacologic treatments with known regulators of adipocyte lipolysis. Furthermore, by combining top hits from a large-scale in vitro chemical screen in 3T3-L1 adipocytes with our reporter we uncovered a novel role for nitric oxide in modulating adipocyte lipolysis and adipose tissue dynamics.</p><p>Beyond pharmacologic perturbations, we also demonstrate the power of this line to perform longitudinal analyses of diet-induced perturbations on adipose tissue area across multiple time points. This work yielded compelling insights into the dynamics of adipose tissue response to both prolonged fasting and high-fat diet. Differences in the kinetics of each response suggest a complex relationship between adipose tissue development and the nutritional and energetic requirements of the developing organism, which merits future investigation. Collectively, these data illustrate the potential of our model to yield novel insights into the regulation of visceral adipose tissue, including the context of obesity.</p><p>While our studies show that this tool can be used to increase our understanding of adipocyte biology, it can also be utilized to study lipid droplets in other contexts as well. Lipid droplets are ubiquitous across almost all cell types. Therefore, this model could be applied to study the regulation of lipid droplets in the development and function of other adipose depots and additional cell types, such as muscle and hepatocytes (<xref ref-type="bibr" rid="bib12">Bosma, 2016</xref>; <xref ref-type="bibr" rid="bib75">Wang et al., 2013</xref>). In the disease context, we focused on the role of lipid droplets in cancer, since tumor cells can take up lipids from adipocytes and then package them into lipid droplets (<xref ref-type="bibr" rid="bib3">Balaban et al., 2017</xref>; <xref ref-type="bibr" rid="bib41">Lengyel et al., 2018</xref>; <xref ref-type="bibr" rid="bib55">Nieman et al., 2011</xref>; <xref ref-type="bibr" rid="bib82">Zhang et al., 2018</xref>). This transfer of lipids has been linked to disease progression, making the regulation of lipid release from the lipid droplet through subsequent lipolysis in the tumor cell of particular interest. We found that regulation of lipolysis by ATGL and nitric oxide pathways is conserved between adipocytes and melanoma cells although phenotypes downstream of nitric oxide may be cell type specific. Collectively, this underscores the complexity of lipid droplet regulation and emphasizes the importance of studying these processes in multiple cell types. We believe that our model will serve as a powerful tool to study cell type-specific regulation of lipid droplet biogenesis and function while preserving the endogenous structural and metabolic environment of an in vivo system.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type (species) or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional information</th></tr></thead><tbody><tr><td valign="top">Cell line (<italic>Danio rerio</italic>)</td><td valign="top">ZMEL</td><td valign="top"><xref ref-type="bibr" rid="bib28">Heilmann et al., 2015</xref></td><td valign="top"/><td valign="top">mitfa:BRAFV600E/p53-/-</td></tr><tr><td valign="top">Cell line (<italic>Danio rerio</italic>)</td><td valign="top">ZMEL-LD</td><td valign="top">This paper</td><td valign="top">(-3.5ubb:plin2-tdtomato) in pDestTol2pA2-blastocidin</td><td valign="top"/></tr><tr><td valign="top">Cell line (<italic>Mus musculus</italic>)</td><td valign="top">3T3-L1</td><td valign="top">ZenBio</td><td valign="top">SP-L1-F</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>Danio rerio</italic>)</td><td valign="top"><italic>casper</italic></td><td valign="top"><xref ref-type="bibr" rid="bib76">White et al., 2008</xref></td><td valign="top">mitfaw2/w2;mpv17a9/a9</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>Danio rerio</italic>)</td><td valign="top">(-3.5ubb:plin2-tdtomato)</td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">(-3.5ubb:plin2-tdtomato) in pDestTol2CG2 (plasmid)</td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">(-3.5ubb:plin2-tdtomato) in pDestTol2pA2-blastocidin (plasmid)</td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pDestTol2pA2-blastocidin (plasmid)</td><td valign="top"><xref ref-type="bibr" rid="bib28">Heilmann et al., 2015</xref></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pDestTol2CG2 (plasmid)</td><td valign="top"><xref ref-type="bibr" rid="bib38">Kwan et al., 2007</xref></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">PLIN2 cDNA FWD</td><td valign="top">This paper</td><td valign="top">PCR primer</td><td valign="top">AAAGCAGGCTCCACCATGAGCTTTCTTCTGTACTTGAAACTG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">PLIN2 cDNA REV</td><td valign="top">This paper</td><td valign="top">PCR primer</td><td valign="top">GCCCTTGCTCACCATTTCAGTGACTTGAAGGGTCCTCTGT</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">PLIN2-TMT FWD</td><td valign="top">This paper</td><td valign="top">PCR primer</td><td valign="top">GCCGCCCCCTTCACCATGAGCTTTCTTCTGTACTTGAAAC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">PLIN2-TMT REV</td><td valign="top">This paper</td><td valign="top">PCR primer</td><td valign="top">GCCCTTGCTCACCATTTCAGTGACTTG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">tdTOMATO ME PLIN2 FWD</td><td valign="top">This paper</td><td valign="top">PCR primer</td><td valign="top">ATGGTGAGCAAGGGCGAG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">tdTOMATO ME PLIN2 REV</td><td valign="top">This paper</td><td valign="top">PCR primer</td><td valign="top">GGTGAAGGGGGCGGC</td></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">Cloneamp HiFi PCR Premix</td><td valign="top">Takara</td><td valign="top">Catalog #639298</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">In-Fusion HD Cloning Plus</td><td valign="top">Takara</td><td valign="top">Catalog #638920</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">Gateway LR Clonase Enzyme mix</td><td valign="top">Thermo Fisher</td><td valign="top">Catalog #11791019</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">Zymogen Quick RNA Miniprep Kit</td><td valign="top">Zymo Research</td><td valign="top">Catalog #R1054</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">Invitrogen SuperScriptIII First-Strand Synthesis SuperMix Kit</td><td valign="top">Thermo Fisher</td><td valign="top">Catalog #18080400</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">NucleoSpin Gel and PCR Clean up</td><td valign="top">Takara</td><td valign="top">Catalog #740609.50</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">Free Glycerol Reagent</td><td valign="top">Sigma-Aldrich</td><td valign="top">Catalog #F6428</td><td valign="top"/></tr><tr><td valign="top">Chemical compound</td><td valign="top">Glycerol Standard Solution</td><td valign="top">Sigma-Aldrich</td><td valign="top">Catalog #G7793</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">HCS LipidTOX deep red</td><td valign="top">Thermo Fisher</td><td valign="top">Catalog #H34477</td><td valign="top">1:250 or 1:500</td></tr><tr><td valign="top">Other</td><td valign="top">BODIPY 493/503</td><td valign="top">Thermo Fisher</td><td valign="top">Catalog #D3922</td><td valign="top">5 or 10 ng/µl</td></tr><tr><td valign="top">Other</td><td valign="top">AUTODOT Visualization Dye (MDH)</td><td valign="top">Abcepta</td><td valign="top">Catalog #SM1000a</td><td valign="top">1:500</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Forskolin</td><td valign="top">Sigma-Aldrich</td><td valign="top">Catalog #F6886</td><td valign="top">5 µM (fish)</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Auranofin</td><td valign="top">Sigma-Aldrich</td><td valign="top">Catalog #A6733</td><td valign="top">1 µM (fish), 0.5 µM (cells)</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">JS-K</td><td valign="top">Sigma-Aldrich</td><td valign="top">Catalog #J4137</td><td valign="top">1 µM (fish), 0.5 µM (cells)</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Atglistatin</td><td valign="top">Sigma-Aldrich</td><td valign="top">Catalog #SML1075</td><td valign="top">40 µM</td></tr><tr><td valign="top">Chemical compound</td><td valign="top">Oleic Acid-Albumin</td><td valign="top">Sigma-Aldrich</td><td valign="top">Catalog #O3008-5M</td><td valign="top"/></tr><tr><td valign="top">Chemical compound</td><td valign="top">LOPAC 1280 Library</td><td valign="top">Sigma-Aldrich</td><td valign="top">Catalog #LO1280</td><td valign="top"/></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-RFP antibody (rabbit polyclonal)</td><td valign="top">Rockland</td><td valign="top">Catalog #600-401-379, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2209751">AB_2209751</ext-link></td><td valign="top">(1:500), (1 µL)</td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">MATLAB</td><td valign="top">Mathworks</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">PRISM</td><td valign="top">Graphpad</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">FIJI</td><td valign="top"><xref ref-type="bibr" rid="bib63">Schindelin et al., 2012</xref></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">FlowJo</td><td valign="top">Becton, Dickinson and Company</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">High-fat diet</td><td valign="top">Sparos</td><td valign="top"/><td valign="top">See detailed description of high-fat diet contents in the 'Methods' section below</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Cloning of <italic>-3.5ubb:plin2-tdtomato</italic></title><p>To clone the <italic>plin2</italic> cDNA, tissue from the muscle and heart of adult <italic>casper</italic> zebrafish was dissected, pooled, and then RNA was isolated using the Zymogen Quick RNA Miniprep Kit (Zymo Research, Irvine, USA; catalog #R1054) according to manufacturer's instructions. The Invitrogen SuperScriptIII First-Strand Synthesis SuperMix Kit (Thermo Fisher, Waltham, USA; catalog #18080400) was used according to manufacturer's instructions to produce cDNA. CloneAmp HiFi PCR Premix (Takara, Mountain View, USA; catalog #639298) was used to PCR amplify the PLIN2 cDNA and gel purified via NucleoSpin Gel and PCR Clean Up (Takara, Mountain View, USA; catalog #740609.50). To generate pME-PLIN2-tdTOMATO, the PLIN2 cDNA was inserted on the 5’ end of pME-tdTOMATO using In-Fusion HD Cloning Plus (Takara, Mountain View, USA; catalog #638920). Gateway cloning using the Gateway LR Clonase Enzyme mix (Thermo Fisher, Waltham, USA; catalog #11791019) was employed to create the <italic>-3.5ubb:plin2-tdTomato</italic> construct with p5E-ubb, pME-PLIN2-tdTOMATO, and p3E-polyA into pDestTol2pA2-blastocidin (cells) (<xref ref-type="bibr" rid="bib28">Heilmann et al., 2015</xref>) or pDestTol2CG2 (zebrafish) (<xref ref-type="bibr" rid="bib38">Kwan et al., 2007</xref>).</p></sec><sec id="s4-2"><title>Zebrafish husbandry</title><p>All zebrafish experiments were carried out in accordance with institutional animal protocols. All zebrafish were housed in a temperature- (28.5°C) and light-controlled (14 hr on, 10 hr off) room. Fish were initially housed at a density of five fish per liter and fed three times per day using rotifers and pelleted zebrafish food. Anesthesia was done using Tricaine (Western Chemical Incorporated, Ferndale, USA) with a stock of 4 g/l (protected for light) and diluted until the fish was immobilized. All procedures were approved by and adhered to Institutional Animal Care and Use Committee (IACUC) protocol #12-05-008 through Memorial Sloan Kettering Cancer Center.</p></sec><sec id="s4-3"><title>Generation of <italic>Tg(-3.5ubb:plin2-tdTomato)</italic></title><p>The <italic>ubb:plin2-tdTomato</italic> plasmid was injected into <italic>casper</italic> embryos with Tol2 mRNA to introduce stable integration of the <italic>ubb:plin2-tdTomato</italic> cassette. Fish with GFP+ hearts (due to pDestTol2CG) were selected and outcrossed with <italic>casper</italic> fish to produce the F1 generation. F1 zebrafish with GFP+ hearts and validated PLIN2-tdTOMATO-expressing adipocytes were outcrossed to generate F2 and F3 generation zebrafish for experiments.</p></sec><sec id="s4-4"><title>Zebrafish imaging and analysis</title><p>Zebrafish were imaged using an upright Zeiss AxioZoom V16 Fluorescence Stereo Zoom Microscope with a x0.5 (for adult fish) or x1.0 (for juvenile fish) adjustable objective lens equipped with a motorized stage, brightfield, and Cy5, GFP, and tdTomato filter sets. To acquire images, zebrafish were lightly anesthetized with 0.2% Tricaine. Images were acquired with the Zeiss Zen Pro v2 and exported as CZI files for visualization using FIJI or analysis using FIJI (to manually quantify standard length) and MATLAB (Mathworks, Natick, USA).</p><p>Our adipocyte segmentation approach utilized the Image Processing Toolbox within MATLAB. Because the zebrafish gut is highly autofluorescent, we chose a threshold for the GFP channel to categorize as background signal and subtracted it from a determined threshold for the tdTOMATO channel. We used a set size to crop images around the tdTOMATO-positive signal and created a mask for the adipose tissue. Within the masked area, we applied a higher tdTOMATO threshold to segment the fluorescent signal from the adipocytes. Finally, we quantified the number of pixels above the threshold to quantify adipose tissue area. MATLAB code is available for download at <ext-link ext-link-type="uri" xlink:href="https://github.com/dlumaquin/PLIN2-tdT-Adipo-Quant.git">https://github.com/dlumaquin/PLIN2-tdT-Adipo-Quant.git</ext-link> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:7685014b3ab6f8be60db088943709914c067428d;origin=https://github.com/dlumaquin/PLIN2-tdT-Adipo-Quant.git;visit=swh:1:snp:873e6f71642fc3c59f99618163df2c1c3a1801a7;anchor=swh:1:rev:decae59e912bd79d43f8559d5a4ee32316233153">swh:1:rev:decae59e912bd79d43f8559d5a4ee32316233153</ext-link>); <xref ref-type="bibr" rid="bib1">Anthony, 2021</xref>.</p><p>To quantify BODIPY-stained adipose tissue, we utilized FIJI to autothreshold GFP signal. We removed background autofluorescence by subtracting Cy5 autothresholded signal. We used the polygon tool to outline and quantify the resulting segmented adipose area.</p><p>For visualization purposes, the segmented images were color filtered on Adobe Photoshop from grayscale to gold color scale.</p></sec><sec id="s4-5"><title>BODIPY staining of zebrafish</title><p>Adult zebrafish were placed in tanks with 10 ng/µl BODIPY 493/503 (Thermo Fisher, Waltham, USA; catalog #D3922) for 30 min in the dark. Fish were washed and then placed in new tanks with fresh water for 2 hr. Fish were washed again to remove any residual BODIPY, then anesthetized and imaged as indicated above for whole adipose tissue.</p><p>Higher resolution images of zebrafish adipocytes were acquired using the Zeiss LSM 880 inverted confocal microscope using a x10 objective. Zebrafish were lightly anesthetized with 0.2% Tricaine and mounted on a glass bottom dish (MatTek, Ashland, USA; catalog #P35G-1.5–20 C) with 0.1% low gelling agarose (Sigma-Aldrich, St. Louis, USA; catalog #A9045-25G).</p></sec><sec id="s4-6"><title>Staining to track adipose depot development</title><p>For BODIPY staining, 5, 14, and 21 dpf fish were incubated with 5 ng/µl BODIPY 493/503 in dishes for 30 min in the dark. Fish were washed with fresh E3 every 45 min for 1.5 hr, then anesthetized and imaged as indicated above for whole adipose tissue. 42 dpf and adult zebrafish were stained in p1000 tip boxes for 30 or 15 min, respectively, in the dark. Fish were then placed back on system to wash with fresh water for 1.5 hr and then anesthetized and imaged as indicated below for whole adipose tissue.</p></sec><sec id="s4-7"><title>Image analysis to track adipose depot development</title><p>To track adipose depot development across multiple stages, F2 (-3.5ubb:plin2-tdTomato) zebrafish were outcrossed with <italic>caspers</italic> to generate F3 fish expressing the transgene and control siblings. Control and <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> fish were raised to a standard density of 25 fish per 2.8 l tank. At the appropriate time points, 5, 14, 21, and 42 dpf or adult-stage zebrafish were removed from the tank and stained for BODIPY as described above.</p><p>Images were acquired in three segments per fish along the anterior to posterior axis to capture the entire body of the fish. Adipose depots were classified based on the previously described system (<xref ref-type="bibr" rid="bib50">Minchin and Rawls, 2017a</xref>). To determine the presence of each adipose depot, images were thresholded in FIJI for GFP (BODIPY493/503) or tdTomato (-3.5ubb:plin2-tdTomato) using control fish as the reference. A depot was scored as present based on positive signal corresponding to the presence of adipocytes for at least one sub-depot in the appropriate anatomic location.</p></sec><sec id="s4-8"><title>IHC for tdTOMATO</title><p>Zebrafish were sacrificed in an ice bath for at least 15 min. For adults, zebrafish tails were dissected. For juvenile zebrafish, the entire fish was used for fixation. Selected zebrafish were fixed in 4% paraformaldehyde for 72 hr at 4°C, washed in 70% ethanol for 24 hr, and then paraffin embedded. Fish were sectioned at 5 µm and placed on Apex Adhesive slides, baked at 60°C, and then stained with antibodies against tdTomato (1:500, Rockland, #600-401-379). Histology was performed and stained by Histowiz.</p></sec><sec id="s4-9"><title>Zebrafish fast</title><p><italic>Tg(-3.5ubb:plin2-tdTomato)</italic> F2 fish were outcrossed with <italic>caspers</italic> to generate the F3 generation. F3 fish were raised at a standard density of 25 fish per 2.8 l tank. For BODIPY staining experiments, 21 dpf fish were separated into new tanks that received standard feed or were fasted for 7 days. Prior to imaging, food was withheld for 3–6 hr to clear the gut. Fish were anesthetized with Tricaine and imaged as described above to quantify BODIPY-stained visceral adipose tissue area and standard length. For the time course fast, 21 dpf <italic>Tg(-3.5ubb:plin2-tdTomato</italic>) fish were separated into new tanks that received standard feed or fasted. Prior to imaging, food was withheld for 3–6 hr to clear the gut. Fish were anesthetized with Tricaine and imaged on days 0, 2, 5, and 7 to quantify PLIN2-tdTOMATO-positive visceral adipose tissue area and standard length.</p></sec><sec id="s4-10"><title>High-fat diet feeding</title><p><italic>Tg(-3.5ubb:plin2-tdTomato)</italic> F3 zebrafish were raised at a standard density of 25 fish per 2.8 l tank. At 21 dpf, the zebrafish were placed in 0.8 l tanks and fed either a high-fat or control diet (Sparos, Portugal) for up to 14 days. Fish were then imaged for PLIN2-tdTOMATO expression at days 0, 7, and 14 after the start of diet. Prior to imaging, fish were put in a new tank and food withheld for ~16 hr. Zebrafish were at equal density for control and experimental groups, ranging from 15 to 30 fish per tank. Fish were fed 0.1 g feed per tank per day split over two feedings. The high-fat and control diets were customized and produced at Sparos Lda (Olhão, Portugal), where powder ingredients were initially mixed according to each target formulation in a double-helix mixer, and thereafter ground twice in a micropulverizer hammer mill (SH1; Hosokawa-Alpine, Germany). The oil fraction of the formulation was subsequently added and diets were humidified and agglomerated through low-shear extrusion (Dominioni Group, Italy). Upon extrusion, diets were dried in a convection oven (OP 750-UF; LTE Scientifics, United Kingdom) for 4 hr at 60°C, and subsequently crumbled (Neuero Farm, Germany) and sieved to 400 μm. Experimental diets were analyzed for proximal composition. The Sparos control diet contains 30% fishmeal, 33% squid meal, 5% fish gelatin, 5.5% wheat gluten, 12% cellulose, 2.5% soybean oil, 2.5% rapeseed oil, 2% vitamins and minerals, 0.1% vitamin E, 0.4% antioxidant, 2% monocalcium phosphate, and 2.2% calcium silicate. The Sparos HFD contains 30% fishmeal, 33% squid meal, 5% fish gelatin, 5.5% wheat gluten, 12% palm oil, 2.5% soybean oil, 2.5% rapeseed oil, 2% vitamins and minerals, 0.1% vitamin E, 0.4% antioxidant, 2% monocalcium phosphate, and 2.2% calcium silicate.</p></sec><sec id="s4-11"><title>3T3-L1 cell culture</title><p>3T3-L1 cells were acquired from ZenBio and their differentiation protocol was followed. Cells were received at passage 8 and split to a maximum of passage 12 as per the recommendations of the company. 96-well plates were coated with fibronectin (EMD Millipore, Burlington, USA; catalog #FC010) diluted 1:100 in phosphate-buffered saline (PBS) for at least 30 min to promote improved adherence of cells to the dish. 3T3-L1 cells were first cultured in PM-1-L1 Preadipocyte Medium and allowed to grow to 100% confluence. PM-1-L1 medium was changed every 48–72 hr. 48 hr after reaching 100% confluence, cells were changed to DM-1-L1 Differentiation Medium for 72 hr and then changed to AM-1-L1 Adipocyte Medium. AM-1-L1 Adipocyte Medium was changed every 48–72 hr. Once in AM-1-L1, the medium was changed gently with a multichannel pipette, and only 150 µl of the 200 µl was replaced to prevent touching the bottom of the well with the pipette tip. After 2–3 weeks in AM-1-L1, the 3T3-L1 developed significantly large lipid droplets and were used in the screen.</p></sec><sec id="s4-12"><title>LOPAC library screen</title><p>The LOPAC library includes 1280 clinically relevant compounds with annotated targets or pathways. The workflow of the screen involved drug or vehicle control of the 3T3-L1 adipocytes for 24 hr in serum-free media. After 24 hr, 100 µl of the media supernatant was collected to measure secreted glycerol using the Free Glycerol Reagent (Sigma-Aldrich, St. Louis, USA; catalog F6428) following the associated glycerol assay protocol.</p><p>The medium (screen media) used for drug treatment was phenol-free DMEM supplemented with 0.2% BSA FFA-free (Sigma-Aldrich, St. Louis, USA; catalog 9048-46-8). The 1280 compounds were aliquoted as 2 µl at 1 mM into 16 × 96-well plates and stored at −20°C. Upon thawing, 198 µl of screen media was added to the well, bringing the final drug concentration for all compounds in the screen to 10 µM. Control vehicle was 1% DMSO served as a negative control and 1 uM isoproterenol served as a positive control in the screen. This medium containing LOPAC drugs, DMSO, and isoproterenol was transferred to 3T3-L1 cells and incubated for 24 hr.</p><p>To measure glycerol release as a readout for lipolysis, 100 µl of Free Glycerol Reagent was aliquoted per well of a 96-well plate. 10 µl of supernatant media from 3T3-L1 adipocytes was then added to each well. A standard curve was produced by using Glycerol Standard Solution (Sigma-Aldrich, St. Louis, USA; catalog G7793). The plate was incubated at 37°C for 5 min and then developed with a plate reader set to detect absorbance at 540 nm. Using the standard curve, a fit equation was developed in Excel to convert the absorbance values into glycerol concentrations. To take into account differences that occur in wells on the edge versus middle of the plate, all well positions across all plates in the screen were averaged to create a normalization factor for any given position on the plate. These normalized values were then used to determine top hits for compounds that block lipolysis.</p></sec><sec id="s4-13"><title>Glycerol release assay with Atglistatin</title><p>3T3-L1s were differentiated on a fibronectin-coated 96-well dish. At the start of the lipolysis experiment, 3T3-L1s were changed to serum-free DMEM supplemented with 0.2% BSA FFA-free (Sigma-Aldrich, St. Louis, USA; catalog 9048-46-8). The medium was supplemented with 1% DMSO for negative control or 1 uM isoproterenol to induce lipolysis or ±100 µM Atglistatin (Sigma-Aldrich, St. Louis, USA; catalog SML1075) to block lipolysis and cells were incubated for 24 hr.</p><p>To measure glycerol release, 100 µl of Free Glycerol Reagent was aliquoted per well of a new 96-well plate. 10 µl of supernatant media from 3T3-L1 adipocytes was then added to each well. A standard curve was produced by using Glycerol Standard Solution (Sigma-Aldrich, St. Louis, USA; catalog G7793). The plate was incubated at 37°C for 5 min and then developed with a plate reader set to detect absorbance at 540 nm. Using the standard curve, a fit equation was developed in Excel to convert the absorbance values into glycerol concentrations.</p></sec><sec id="s4-14"><title>Zebrafish drug treatments</title><p><italic>Tg(-3.5ubb:plin2-tdTomato)</italic> zebrafish were outcrossed with <italic>caspers</italic> to generate the F2 or F3 generation. F2 or F3 fish were raised at a standard density of 50 fish per 6.0 l tank. For drug treatment, fish were removed from the system at 21 dpf and placed at a density of one fish per well in a six-well plate with 10 ml of E3 per well. To evaluate viability, fish were treated for 24 hr and quantified for live and dead larvae. After a 24 hr incubation with the drug, fish were anesthetized with Tricaine and imaged using the described protocol to quantify (1) standard length and (2) area of PLIN2-tdTOMATO expression corresponding to visceral adipose tissue area. Fish were treated with Forskolin (Sigma-Aldrich, St. Louis, USA; catalog #F6886), Auranofin (Sigma-Aldrich, St. Louis, USA; catalog #A6733), JS-K (Sigma-Aldrich, St. Louis, USA; catalog #J4137), or Atglistatin (Sigma-Aldrich, St. Louis, USA; catalog #SML1075[1]), which were all dissolved in DMSO.</p></sec><sec id="s4-15"><title>Generation of ZMEL-LD cell line</title><p>The ZMEL zebrafish melanoma cell line was derived from a tumor of a <italic>mitfa:BRAF<sup>V600E</sup>/p53<sup>-/-</sup></italic> zebrafish as described previously (<xref ref-type="bibr" rid="bib28">Heilmann et al., 2015</xref>). ZMEL cells constitutively express eGFP driven by the <italic>mitfa</italic> promoter (<xref ref-type="bibr" rid="bib28">Heilmann et al., 2015</xref>). ZMEL cells were grown at 28°C in a humidified incubator in DMEM (Gibco, Waltham, USA; catalog #11965) supplemented with 10% fetal bovine serum (FBS) (Gemini Bio, #100–500), 1x penicillin/streptomycin/glutamine (Gibco, Waltham, USA; catalog #10378016), and 1x GlutaMAX (Gibco, Waltham, USA; catalog #35050061). To generate the ZMEL-LD cells, ZMEL cells were nucleofected with the <italic>ubb:plin2-tdtomato</italic> plasmid using the Neon Transfection System (Thermo Fisher, Waltham, USA; catalog #MPK10096), selected for 2 weeks in blasticidine-supplemented media at 4 µg/µl (Sigma-Aldrich, St. Louis, USA; catalog #15205–25 MG), and FACS sorted for GFP and tdTOMATO double-positive cells. ZMEL and ZMEL-LD cells underwent routine <italic>Mycoplasma</italic> testing, most recently in January 2021.</p></sec><sec id="s4-16"><title>ZMEL-GFP and ZMEL-LD imaging</title><p>Eight-well Nunc Lab-Tek Chambered Coverglass was coated with 1:100 dilution of fibronectin in Dulbecco's Phosphate Buffered Saline (DPBS) (Millipore Sigma, Burlington, USA; catalog #FC010-5MG) for 30 min and then washed with DPBS (Thermo Scientific, Waltham, USA; catalog #14190–250). ZMEL-GFP or ZMEL-LD cells were seeded at 30,000 cells per well and left to adhere for 24 hr. A medium supplemented with oleic acid (Sigma-Aldrich, St. Louis, USA; catalog #O3008-5ML) was added for 24 hr. Cells were fixed with 2% paraformaldehyde (Santa Cruz Biotechnology, Santa Cruz, USA; catalog #sc-281692) for 45 min and washed with DPBS. For MDH staining, cells were permeabilized with 0.1% Triton-X (Thermo Fisher, Waltham, USA; catalog #PI85111) for 30 min at room temperature, washed, and stained with 1:500 MDH (Abcepta, San Diego, USA; catalog #SM1000a) for 15 min. Cells were imaged on the Zeiss LSM 880 inverted confocal microscope with AiryScan using a x63 oil immersion objective. For Lipid staining, cells were stained with 1:500 Lipidtox Deep Red (Thermo Fisher, Waltham, USA; catalog #H34477) and 1:2000 Hoechst 33342 (Thermo Fisher, Waltham, USA; catalog #H3570) for 30 min. Cells were imaged on the Zeiss LSM 880 inverted confocal microscope using a x40 oil immersion objective. Confocal stacks were visualized via FIJI, and 3D reconstruction was created using Imaris (Bitplane Inc, Concord, USA).</p></sec><sec id="s4-17"><title>ZMEL-LD FACS analysis</title><p>ZMEL Dark (no fluorescence), ZMEL-GFP, and ZMEL-LD cells were plated on fibronectin-coated six-well plates at a density of 500,000 cells in 1 ml of media per well. At 24 hr after plating, cells were given either 150 µM of BSA or oleic acid with 1 µl of DMSO. At 48 and 72 hr after plating, lipid droplet low and high controls were switched to fresh media with 150 µM of BSA or oleic acid with 1 µl of DMSO. Cells pulsed with oleic acid received fresh media with 150 µM of BSA with either 40 µM Atglistatin, 0.5 µM Auranofin, or 0.5 µM JS-K. At 96 hr after plating, cells were trypsinized, washed with DPBS, and resuspended in DMEM supplemented with 2% FBS, 1x penicillin/streptomycin/glutamine, and 1x GlutaMAX. Cells were stained for viability with 1:1000 DAPI and strained through the Falcon FACS Tube with Cell Strainer Cap (Thermo Fisher, Waltham, USA; catalog #08-771-23). For Lipidtox comparison, cells were given either BSA or indicated concentrations of oleic acid for 24 hr. Cells were trypsinized, washed with DPBS, stained with 1:250 Lipid Deep Red and 1:1000 DAPI for 10 min, and strained through the Falcon FACS Tube with Cell Strainer Cap. Data was acquired via the Beckman Coulter CytoFLEX Flow Cytometer (Beckman Coulter, Miami, USA) and analyzed using FlowJo software (BD Biosciences, San Jose, USA).</p></sec><sec id="s4-18"><title>Schematics</title><p>Schematics and illustrations were generated using Biorender on <ext-link ext-link-type="uri" xlink:href="https://biorender.com/">biorender.com</ext-link>.</p></sec><sec id="s4-19"><title>Statistics</title><p>All statistical analyses were performed using GraphPad Prism 8 (Graphpad, San Diego, USA). Data are presented as mean ± 95% confidence interval (CI) or standard error of the mean (SEM). p&lt;0.05 was considered statistically significant. Statistical tests used are noted in the figure legend. All experiments were done with at least three independent replicates. For in vivo experiments, N denotes the number of independent experiments while n denotes the number of individual fish. Imaging analyses utilized FIJI, Imaris, and MATLAB software.</p></sec><sec id="s4-20"><title>Availability of resources</title><p>All zebrafish cell lines and transgenic lines are available upon request. In addition, the <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> zebrafish will be deposited at the Zebrafish International Resource Center.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank members at the Memorial Sloan Kettering Cancer Center Aquatics Core, Molecular Cytology Core, and Flow Cytometry Core for their contributions to this work. We thank Dr. Mohita Tagore and Dr. Ting-Hsiang (Richard) Huang for comments on the project and manuscript.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf2"><p>Richard White: Senior editor, eLife. Is a paid consultant to N-of-One Therapeutics, a subsidiary of Qiagen. Is on thescientific advisory board of Consano, but receives no income for this. Receives royalty payments for the use of the casper zebrafish line from Carolina Biologicals.</p></fn><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Data curation, Formal analysis, Investigation</p></fn><fn fn-type="con" id="con5"><p>Data curation, Investigation</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Supervision, Funding acquisition, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#12-05-008) of Memorial Sloan Kettering Cancer Center. The protocol was approved by the Committee on the Ethics of Animal Experiments of Memorial Sloan Kettering Cancer Center (Permit Number: D16-00199). Every effort was made to minimize suffering.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-64744-transrepform-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 2-5 and Figure 2-figure supplement 1, Figure 3-figure supplement 1 and Figure 5-figure supplement 1.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Anthony</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>PLIN2-tdT-Adipo-Quant.git </data-title><source>Software Heritage</source><version designator="swh:1:rev:decae59e912bd79d43f8559d5a4ee32316233153">swh:1:rev:decae59e912bd79d43f8559d5a4ee32316233153</version><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:rev:decae59e912bd79d43f8559d5a4ee32316233153">https://archive.softwareheritage.org/swh:1:rev:decae59e912bd79d43f8559d5a4ee32316233153</ext-link></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname> <given-names>AP</given-names></name><name><surname>Koster</surname> <given-names>G</given-names></name><name><surname>Guillermier</surname> <given-names>C</given-names></name><name><surname>Hirst</surname> <given-names>EM</given-names></name><name><surname>MacRae</surname> <given-names>JI</given-names></name><name><surname>Lechene</surname> <given-names>CP</given-names></name><name><surname>Postle</surname> <given-names>AD</given-names></name><name><surname>Gould</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Antioxidant role for lipid droplets in a stem cell niche of <italic>Drosophila</italic></article-title><source>Cell</source><volume>163</volume><fpage>340</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.09.020</pub-id><pub-id pub-id-type="pmid">26451484</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balaban</surname> <given-names>S</given-names></name><name><surname>Shearer</surname> <given-names>RF</given-names></name><name><surname>Lee</surname> <given-names>LS</given-names></name><name><surname>van Geldermalsen</surname> <given-names>M</given-names></name><name><surname>Schreuder</surname> <given-names>M</given-names></name><name><surname>Shtein</surname> <given-names>HC</given-names></name><name><surname>Cairns</surname> <given-names>R</given-names></name><name><surname>Thomas</surname> <given-names>KC</given-names></name><name><surname>Fazakerley</surname> <given-names>DJ</given-names></name><name><surname>Grewal</surname> <given-names>T</given-names></name><name><surname>Holst</surname> <given-names>J</given-names></name><name><surname>Saunders</surname> <given-names>DN</given-names></name><name><surname>Hoy</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Adipocyte lipolysis links obesity to breast Cancer growth: adipocyte-derived fatty acids drive breast Cancer cell proliferation and migration</article-title><source>Cancer &amp; Metabolism</source><volume>5</volume><elocation-id>1</elocation-id><pub-id pub-id-type="doi">10.1186/s40170-016-0163-7</pub-id><pub-id pub-id-type="pmid">28101337</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barba</surname> <given-names>G</given-names></name><name><surname>Harper</surname> <given-names>F</given-names></name><name><surname>Harada</surname> <given-names>T</given-names></name><name><surname>Kohara</surname> <given-names>M</given-names></name><name><surname>Goulinet</surname> <given-names>S</given-names></name><name><surname>Matsuura</surname> <given-names>Y</given-names></name><name><surname>Eder</surname> <given-names>G</given-names></name><name><surname>Schaff</surname> <given-names>Z</given-names></name><name><surname>Chapman</surname> <given-names>MJ</given-names></name><name><surname>Miyamura</surname> <given-names>T</given-names></name><name><surname>Bréchot</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets</article-title><source>PNAS</source><volume>94</volume><fpage>1200</fpage><lpage>1205</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.4.1200</pub-id><pub-id pub-id-type="pmid">9037030</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beller</surname> <given-names>M</given-names></name><name><surname>Bulankina</surname> <given-names>AV</given-names></name><name><surname>Hsiao</surname> <given-names>HH</given-names></name><name><surname>Urlaub</surname> <given-names>H</given-names></name><name><surname>Jäckle</surname> <given-names>H</given-names></name><name><surname>Kühnlein</surname> <given-names>RP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>PERILIPIN-dependent control of lipid droplet structure and fat storage in <italic>Drosophila</italic></article-title><source>Cell Metabolism</source><volume>12</volume><fpage>521</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2010.10.001</pub-id><pub-id pub-id-type="pmid">21035762</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bensaad</surname> <given-names>K</given-names></name><name><surname>Favaro</surname> <given-names>E</given-names></name><name><surname>Lewis</surname> <given-names>CA</given-names></name><name><surname>Peck</surname> <given-names>B</given-names></name><name><surname>Lord</surname> <given-names>S</given-names></name><name><surname>Collins</surname> <given-names>JM</given-names></name><name><surname>Pinnick</surname> <given-names>KE</given-names></name><name><surname>Wigfield</surname> <given-names>S</given-names></name><name><surname>Buffa</surname> <given-names>FM</given-names></name><name><surname>Li</surname> <given-names>JL</given-names></name><name><surname>Zhang</surname> <given-names>Q</given-names></name><name><surname>Wakelam</surname> <given-names>MJO</given-names></name><name><surname>Karpe</surname> <given-names>F</given-names></name><name><surname>Schulze</surname> <given-names>A</given-names></name><name><surname>Harris</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Fatty acid uptake and lipid storage induced by HIF-1α contribute to cell growth and survival after hypoxia-reoxygenation</article-title><source>Cell Reports</source><volume>9</volume><fpage>349</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.08.056</pub-id><pub-id pub-id-type="pmid">25263561</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergman</surname> <given-names>RN</given-names></name><name><surname>Van Citters</surname> <given-names>GW</given-names></name><name><surname>Mittelman</surname> <given-names>SD</given-names></name><name><surname>Dea</surname> <given-names>MK</given-names></name><name><surname>Hamilton-Wessler</surname> <given-names>M</given-names></name><name><surname>Kim</surname> <given-names>SP</given-names></name><name><surname>Ellmerer</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Central role of the adipocyte in the metabolic syndrome</article-title><source>Journal of Investigative Medicine</source><volume>49</volume><fpage>119</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.2310/6650.2001.34108</pub-id><pub-id pub-id-type="pmid">11217141</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname> <given-names>R</given-names></name><name><surname>Church</surname> <given-names>CD</given-names></name><name><surname>Gericke</surname> <given-names>MT</given-names></name><name><surname>Jeffery</surname> <given-names>E</given-names></name><name><surname>Colman</surname> <given-names>L</given-names></name><name><surname>Rodeheffer</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Imaging of adipose tissue</article-title><source>Methods in Enzymology</source><volume>537</volume><fpage>47</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-411619-1.00004-5</pub-id><pub-id pub-id-type="pmid">24480341</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname> <given-names>R</given-names></name><name><surname>Rodeheffer</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Characterization of the adipocyte cellular lineage in vivo</article-title><source>Nature Cell Biology</source><volume>15</volume><fpage>302</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1038/ncb2696</pub-id><pub-id pub-id-type="pmid">23434825</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosch</surname> <given-names>M</given-names></name><name><surname>Sánchez-Álvarez</surname> <given-names>M</given-names></name><name><surname>Fajardo</surname> <given-names>A</given-names></name><name><surname>Kapetanovic</surname> <given-names>R</given-names></name><name><surname>Steiner</surname> <given-names>B</given-names></name><name><surname>Dutra</surname> <given-names>F</given-names></name><name><surname>Moreira</surname> <given-names>L</given-names></name><name><surname>López</surname> <given-names>JA</given-names></name><name><surname>Campo</surname> <given-names>R</given-names></name><name><surname>Marí</surname> <given-names>M</given-names></name><name><surname>Morales-Paytuví</surname> <given-names>F</given-names></name><name><surname>Tort</surname> <given-names>O</given-names></name><name><surname>Gubern</surname> <given-names>A</given-names></name><name><surname>Templin</surname> <given-names>RM</given-names></name><name><surname>Curson</surname> <given-names>JEB</given-names></name><name><surname>Martel</surname> <given-names>N</given-names></name><name><surname>Català</surname> <given-names>C</given-names></name><name><surname>Lozano</surname> <given-names>F</given-names></name><name><surname>Tebar</surname> <given-names>F</given-names></name><name><surname>Enrich</surname> <given-names>C</given-names></name><name><surname>Vázquez</surname> <given-names>J</given-names></name><name><surname>Del Pozo</surname> <given-names>MA</given-names></name><name><surname>Sweet</surname> <given-names>MJ</given-names></name><name><surname>Bozza</surname> <given-names>PT</given-names></name><name><surname>Gross</surname> <given-names>SP</given-names></name><name><surname>Parton</surname> <given-names>RG</given-names></name><name><surname>Pol</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense</article-title><source>Science</source><volume>370</volume><elocation-id>eaay8085</elocation-id><pub-id pub-id-type="doi">10.1126/science.aay8085</pub-id><pub-id pub-id-type="pmid">33060333</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosma</surname> <given-names>M</given-names></name><name><surname>Dapito</surname> <given-names>DH</given-names></name><name><surname>Drosatos-Tampakaki</surname> <given-names>Z</given-names></name><name><surname>Huiping-Son</surname> <given-names>N</given-names></name><name><surname>Huang</surname> <given-names>LS</given-names></name><name><surname>Kersten</surname> <given-names>S</given-names></name><name><surname>Drosatos</surname> <given-names>K</given-names></name><name><surname>Goldberg</surname> <given-names>IJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Sequestration of fatty acids in triglycerides prevents endoplasmic reticulum stress in an in vitro model of cardiomyocyte lipotoxicity</article-title><source>Biochimica Et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids</source><volume>1841</volume><fpage>1648</fpage><lpage>1655</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2014.09.012</pub-id><pub-id pub-id-type="pmid">25251292</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosma</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Lipid droplet dynamics in skeletal muscle</article-title><source>Experimental Cell Research</source><volume>340</volume><fpage>180</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2015.10.023</pub-id><pub-id pub-id-type="pmid">26515552</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabodevilla</surname> <given-names>AG</given-names></name><name><surname>Sánchez-Caballero</surname> <given-names>L</given-names></name><name><surname>Nintou</surname> <given-names>E</given-names></name><name><surname>Boiadjieva</surname> <given-names>VG</given-names></name><name><surname>Picatoste</surname> <given-names>F</given-names></name><name><surname>Gubern</surname> <given-names>A</given-names></name><name><surname>Claro</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cell survival during complete nutrient deprivation depends on lipid droplet-fueled β-oxidation of fatty acids</article-title><source>Journal of Biological Chemistry</source><volume>288</volume><fpage>27777</fpage><lpage>27788</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.466656</pub-id><pub-id pub-id-type="pmid">23940052</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carten</surname> <given-names>JD</given-names></name><name><surname>Bradford</surname> <given-names>MK</given-names></name><name><surname>Farber</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Visualizing digestive organ morphology and function using differential fatty acid metabolism in live zebrafish</article-title><source>Developmental Biology</source><volume>360</volume><fpage>276</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2011.09.010</pub-id><pub-id pub-id-type="pmid">21968100</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chi</surname> <given-names>J</given-names></name><name><surname>Crane</surname> <given-names>A</given-names></name><name><surname>Wu</surname> <given-names>Z</given-names></name><name><surname>Cohen</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Adipo-Clear: a tissue clearing method for Three-Dimensional imaging of adipose tissue</article-title><source>Journal of Visualized Experiments</source><volume>1</volume><elocation-id>58271</elocation-id><pub-id pub-id-type="doi">10.3791/58271</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chitraju</surname> <given-names>C</given-names></name><name><surname>Mejhert</surname> <given-names>N</given-names></name><name><surname>Haas</surname> <given-names>JT</given-names></name><name><surname>Diaz-Ramirez</surname> <given-names>LG</given-names></name><name><surname>Grueter</surname> <given-names>CA</given-names></name><name><surname>Imbriglio</surname> <given-names>JE</given-names></name><name><surname>Pinto</surname> <given-names>S</given-names></name><name><surname>Koliwad</surname> <given-names>SK</given-names></name><name><surname>Walther</surname> <given-names>TC</given-names></name><name><surname>Farese</surname> <given-names>RV</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Triglyceride synthesis by DGAT1 protects adipocytes from Lipid-Induced ER stress during lipolysis</article-title><source>Cell Metabolism</source><volume>26</volume><fpage>407</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.07.012</pub-id><pub-id pub-id-type="pmid">28768178</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname> <given-names>CY</given-names></name><name><surname>Chen</surname> <given-names>CF</given-names></name><name><surname>Rajendran</surname> <given-names>RS</given-names></name><name><surname>Shen</surname> <given-names>CN</given-names></name><name><surname>Chen</surname> <given-names>TH</given-names></name><name><surname>Yen</surname> <given-names>CC</given-names></name><name><surname>Chuang</surname> <given-names>CK</given-names></name><name><surname>Lin</surname> <given-names>DS</given-names></name><name><surname>Hsiao</surname> <given-names>CD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Overexpression of Akt1 enhances adipogenesis and leads to lipoma formation in zebrafish</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e36474</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0036474</pub-id><pub-id pub-id-type="pmid">22623957</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daemen</surname> <given-names>S</given-names></name><name><surname>van Zandvoort</surname> <given-names>M</given-names></name><name><surname>Parekh</surname> <given-names>SH</given-names></name><name><surname>Hesselink</surname> <given-names>MKC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Microscopy tools for the investigation of intracellular lipid storage and dynamics</article-title><source>Molecular Metabolism</source><volume>5</volume><fpage>153</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/j.molmet.2015.12.005</pub-id><pub-id pub-id-type="pmid">26977387</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname> <given-names>RE</given-names></name><name><surname>Ahmadian</surname> <given-names>M</given-names></name><name><surname>Jaworski</surname> <given-names>K</given-names></name><name><surname>Sarkadi-Nagy</surname> <given-names>E</given-names></name><name><surname>Sul</surname> <given-names>HS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Regulation of lipolysis in adipocytes</article-title><source>Annual Review of Nutrition</source><volume>27</volume><fpage>79</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1146/annurev.nutr.27.061406.093734</pub-id><pub-id pub-id-type="pmid">17313320</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fam</surname> <given-names>T</given-names></name><name><surname>Klymchenko</surname> <given-names>A</given-names></name><name><surname>Collot</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Recent advances in fluorescent probes for lipid droplets</article-title><source>Materials</source><volume>11</volume><elocation-id>1768</elocation-id><pub-id pub-id-type="doi">10.3390/ma11091768</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farber</surname> <given-names>SA</given-names></name><name><surname>Pack</surname> <given-names>M</given-names></name><name><surname>Ho</surname> <given-names>SY</given-names></name><name><surname>Johnson</surname> <given-names>ID</given-names></name><name><surname>Wagner</surname> <given-names>DS</given-names></name><name><surname>Dosch</surname> <given-names>R</given-names></name><name><surname>Mullins</surname> <given-names>MC</given-names></name><name><surname>Hendrickson</surname> <given-names>HS</given-names></name><name><surname>Hendrickson</surname> <given-names>EK</given-names></name><name><surname>Halpern</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Genetic analysis of digestive physiology using fluorescent phospholipid reporters</article-title><source>Science</source><volume>292</volume><fpage>1385</fpage><lpage>1388</lpage><pub-id pub-id-type="doi">10.1126/science.1060418</pub-id><pub-id pub-id-type="pmid">11359013</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fei</surname> <given-names>W</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Fu</surname> <given-names>X</given-names></name><name><surname>Bielby</surname> <given-names>C</given-names></name><name><surname>Yang</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Conditions of endoplasmic reticulum stress stimulate lipid droplet formation in <italic>Saccharomyces cerevisiae</italic></article-title><source>Biochemical Journal</source><volume>424</volume><fpage>61</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1042/BJ20090785</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname> <given-names>CS</given-names></name><name><surname>Massaro</surname> <given-names>JM</given-names></name><name><surname>Hoffmann</surname> <given-names>U</given-names></name><name><surname>Pou</surname> <given-names>KM</given-names></name><name><surname>Maurovich-Horvat</surname> <given-names>P</given-names></name><name><surname>Liu</surname> <given-names>C-Y</given-names></name><name><surname>Vasan</surname> <given-names>RS</given-names></name><name><surname>Murabito</surname> <given-names>JM</given-names></name><name><surname>Meigs</surname> <given-names>JB</given-names></name><name><surname>Cupples</surname> <given-names>LA</given-names></name><name><surname>D’Agostino</surname> <given-names>RB</given-names></name><name><surname>O’Donnell</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Abdominal visceral and subcutaneous adipose tissue compartments</article-title><source>Circulation</source><volume>116</volume><fpage>39</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.675355</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimoto</surname> <given-names>Y</given-names></name><name><surname>Itabe</surname> <given-names>H</given-names></name><name><surname>Kinoshita</surname> <given-names>T</given-names></name><name><surname>Homma</surname> <given-names>KJ</given-names></name><name><surname>Onoduka</surname> <given-names>J</given-names></name><name><surname>Mori</surname> <given-names>M</given-names></name><name><surname>Yamaguchi</surname> <given-names>S</given-names></name><name><surname>Makita</surname> <given-names>M</given-names></name><name><surname>Higashi</surname> <given-names>Y</given-names></name><name><surname>Yamashita</surname> <given-names>A</given-names></name><name><surname>Takano</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Involvement of ACSL in local synthesis of neutral lipids in cytoplasmic lipid droplets in human hepatocyte HuH7</article-title><source>Journal of Lipid Research</source><volume>48</volume><fpage>1280</fpage><lpage>1292</lpage><pub-id pub-id-type="doi">10.1194/jlr.M700050-JLR200</pub-id><pub-id pub-id-type="pmid">17379924</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimoto</surname> <given-names>M</given-names></name><name><surname>Matsuzaki</surname> <given-names>I</given-names></name><name><surname>Nishitsuji</surname> <given-names>K</given-names></name><name><surname>Yamamoto</surname> <given-names>Y</given-names></name><name><surname>Murakami</surname> <given-names>D</given-names></name><name><surname>Yoshikawa</surname> <given-names>T</given-names></name><name><surname>Fukui</surname> <given-names>A</given-names></name><name><surname>Mori</surname> <given-names>Y</given-names></name><name><surname>Nishino</surname> <given-names>M</given-names></name><name><surname>Takahashi</surname> <given-names>Y</given-names></name><name><surname>Iwahashi</surname> <given-names>Y</given-names></name><name><surname>Warigaya</surname> <given-names>K</given-names></name><name><surname>Kojima</surname> <given-names>F</given-names></name><name><surname>Jinnin</surname> <given-names>M</given-names></name><name><surname>Murata</surname> <given-names>SI</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Adipophilin expression in cutaneous malignant melanoma is associated with high proliferation and poor clinical prognosis</article-title><source>Laboratory Investigation</source><volume>100</volume><fpage>727</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1038/s41374-019-0358-y</pub-id><pub-id pub-id-type="pmid">31857696</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimoto</surname> <given-names>T</given-names></name><name><surname>Parton</surname> <given-names>RG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Not just fat: the structure and function of the lipid droplet</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>3</volume><elocation-id>a004838</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a004838</pub-id><pub-id pub-id-type="pmid">21421923</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heid</surname> <given-names>H</given-names></name><name><surname>Rickelt</surname> <given-names>S</given-names></name><name><surname>Zimbelmann</surname> <given-names>R</given-names></name><name><surname>Winter</surname> <given-names>S</given-names></name><name><surname>Schumacher</surname> <given-names>H</given-names></name><name><surname>Dörflinger</surname> <given-names>Y</given-names></name><name><surname>Kuhn</surname> <given-names>C</given-names></name><name><surname>Franke</surname> <given-names>WW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>On the formation of lipid droplets in human adipocytes: the organization of the perilipin-vimentin cortex</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e90386</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0090386</pub-id><pub-id pub-id-type="pmid">24587346</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heilmann</surname> <given-names>S</given-names></name><name><surname>Ratnakumar</surname> <given-names>K</given-names></name><name><surname>Langdon</surname> <given-names>E</given-names></name><name><surname>Kansler</surname> <given-names>E</given-names></name><name><surname>Kim</surname> <given-names>I</given-names></name><name><surname>Campbell</surname> <given-names>NR</given-names></name><name><surname>Perry</surname> <given-names>E</given-names></name><name><surname>McMahon</surname> <given-names>A</given-names></name><name><surname>Kaufman</surname> <given-names>C</given-names></name><name><surname>van Rooijen</surname> <given-names>E</given-names></name><name><surname>Lee</surname> <given-names>W</given-names></name><name><surname>Iacobuzio-Donahue</surname> <given-names>C</given-names></name><name><surname>Hynes</surname> <given-names>R</given-names></name><name><surname>Zon</surname> <given-names>L</given-names></name><name><surname>Xavier</surname> <given-names>J</given-names></name><name><surname>White</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A quantitative system for studying metastasis using transparent zebrafish</article-title><source>Cancer Research</source><volume>75</volume><fpage>4272</fpage><lpage>4282</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-14-3319</pub-id><pub-id pub-id-type="pmid">26282170</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hellmér</surname> <given-names>J</given-names></name><name><surname>Arner</surname> <given-names>P</given-names></name><name><surname>Lundin</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Automatic luminometric kinetic assay of glycerol for lipolysis studies</article-title><source>Analytical Biochemistry</source><volume>177</volume><fpage>132</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/0003-2697(89)90027-4</pub-id><pub-id pub-id-type="pmid">2742143</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henne</surname> <given-names>WM</given-names></name><name><surname>Reese</surname> <given-names>ML</given-names></name><name><surname>Goodman</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The assembly of lipid droplets and their roles in challenged cells</article-title><source>The EMBO Journal</source><volume>37</volume><elocation-id>e98947</elocation-id><pub-id pub-id-type="doi">10.15252/embj.201898947</pub-id><pub-id pub-id-type="pmid">29789390</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herms</surname> <given-names>A</given-names></name><name><surname>Bosch</surname> <given-names>M</given-names></name><name><surname>Reddy</surname> <given-names>BJ</given-names></name><name><surname>Schieber</surname> <given-names>NL</given-names></name><name><surname>Fajardo</surname> <given-names>A</given-names></name><name><surname>Rupérez</surname> <given-names>C</given-names></name><name><surname>Fernández-Vidal</surname> <given-names>A</given-names></name><name><surname>Ferguson</surname> <given-names>C</given-names></name><name><surname>Rentero</surname> <given-names>C</given-names></name><name><surname>Tebar</surname> <given-names>F</given-names></name><name><surname>Enrich</surname> <given-names>C</given-names></name><name><surname>Parton</surname> <given-names>RG</given-names></name><name><surname>Gross</surname> <given-names>SP</given-names></name><name><surname>Pol</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>AMPK activation promotes lipid droplet dispersion on detyrosinated microtubules to increase mitochondrial fatty acid oxidation</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>7176</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms8176</pub-id><pub-id pub-id-type="pmid">26013497</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Høgset</surname> <given-names>H</given-names></name><name><surname>Horgan</surname> <given-names>CC</given-names></name><name><surname>Armstrong</surname> <given-names>JPK</given-names></name><name><surname>Bergholt</surname> <given-names>MS</given-names></name><name><surname>Torraca</surname> <given-names>V</given-names></name><name><surname>Chen</surname> <given-names>Q</given-names></name><name><surname>Keane</surname> <given-names>TJ</given-names></name><name><surname>Bugeon</surname> <given-names>L</given-names></name><name><surname>Dallman</surname> <given-names>MJ</given-names></name><name><surname>Mostowy</surname> <given-names>S</given-names></name><name><surname>Stevens</surname> <given-names>MM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>In vivo biomolecular imaging of zebrafish embryos using confocal raman spectroscopy</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>6172</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-19827-1</pub-id><pub-id pub-id-type="pmid">33268772</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarc</surname> <given-names>E</given-names></name><name><surname>Petan</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Lipid droplets and the management of cellular stress</article-title><source>The Yale Journal of Biology and Medicine</source><volume>92</volume><fpage>435</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">31543707</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krahmer</surname> <given-names>N</given-names></name><name><surname>Farese</surname> <given-names>RV</given-names></name><name><surname>Walther</surname> <given-names>TC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Balancing the fat: lipid droplets and human disease</article-title><source>EMBO Molecular Medicine</source><volume>5</volume><fpage>973</fpage><lpage>983</lpage><pub-id pub-id-type="doi">10.1002/emmm.201100671</pub-id><pub-id pub-id-type="pmid">23740690</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuerschner</surname> <given-names>L</given-names></name><name><surname>Moessinger</surname> <given-names>C</given-names></name><name><surname>Thiele</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Imaging of lipid biosynthesis: how a neutral lipid enters lipid droplets</article-title><source>Traffic</source><volume>9</volume><fpage>338</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0854.2007.00689.x</pub-id><pub-id pub-id-type="pmid">18088320</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuniyoshi</surname> <given-names>S</given-names></name><name><surname>Miki</surname> <given-names>Y</given-names></name><name><surname>Sasaki</surname> <given-names>A</given-names></name><name><surname>Iwabuchi</surname> <given-names>E</given-names></name><name><surname>Ono</surname> <given-names>K</given-names></name><name><surname>Onodera</surname> <given-names>Y</given-names></name><name><surname>Hirakawa</surname> <given-names>H</given-names></name><name><surname>Ishida</surname> <given-names>T</given-names></name><name><surname>Yoshimi</surname> <given-names>N</given-names></name><name><surname>Sasano</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The significance of lipid accumulation in breast carcinoma cells through perilipin 2 and its clinicopathological significance</article-title><source>Pathology International</source><volume>69</volume><fpage>463</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1111/pin.12831</pub-id><pub-id pub-id-type="pmid">31273897</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurat</surname> <given-names>CF</given-names></name><name><surname>Wolinski</surname> <given-names>H</given-names></name><name><surname>Petschnigg</surname> <given-names>J</given-names></name><name><surname>Kaluarachchi</surname> <given-names>S</given-names></name><name><surname>Andrews</surname> <given-names>B</given-names></name><name><surname>Natter</surname> <given-names>K</given-names></name><name><surname>Kohlwein</surname> <given-names>SD</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cdk1/Cdc28-dependent activation of the major triacylglycerol lipase Tgl4 in yeast links lipolysis to cell-cycle progression</article-title><source>Molecular Cell</source><volume>33</volume><fpage>53</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2008.12.019</pub-id><pub-id pub-id-type="pmid">19150427</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwan</surname> <given-names>KM</given-names></name><name><surname>Fujimoto</surname> <given-names>E</given-names></name><name><surname>Grabher</surname> <given-names>C</given-names></name><name><surname>Mangum</surname> <given-names>BD</given-names></name><name><surname>Hardy</surname> <given-names>ME</given-names></name><name><surname>Campbell</surname> <given-names>DS</given-names></name><name><surname>Parant</surname> <given-names>JM</given-names></name><name><surname>Yost</surname> <given-names>HJ</given-names></name><name><surname>Kanki</surname> <given-names>JP</given-names></name><name><surname>Chien</surname> <given-names>CB</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs</article-title><source>Developmental Dynamics</source><volume>236</volume><fpage>3088</fpage><lpage>3099</lpage><pub-id pub-id-type="doi">10.1002/dvdy.21343</pub-id><pub-id pub-id-type="pmid">17937395</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landgraf</surname> <given-names>K</given-names></name><name><surname>Schuster</surname> <given-names>S</given-names></name><name><surname>Meusel</surname> <given-names>A</given-names></name><name><surname>Garten</surname> <given-names>A</given-names></name><name><surname>Riemer</surname> <given-names>T</given-names></name><name><surname>Schleinitz</surname> <given-names>D</given-names></name><name><surname>Kiess</surname> <given-names>W</given-names></name><name><surname>Körner</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Short-term overfeeding of zebrafish with normal or high-fat diet as a model for the development of metabolically healthy versus unhealthy obesity</article-title><source>BMC Physiology</source><volume>17</volume><elocation-id>4</elocation-id><pub-id pub-id-type="doi">10.1186/s12899-017-0031-x</pub-id><pub-id pub-id-type="pmid">28327129</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Jemtel</surname> <given-names>TH</given-names></name><name><surname>Samson</surname> <given-names>R</given-names></name><name><surname>Milligan</surname> <given-names>G</given-names></name><name><surname>Jaiswal</surname> <given-names>A</given-names></name><name><surname>Oparil</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Visceral adipose tissue accumulation and residual cardiovascular risk</article-title><source>Current Hypertension Reports</source><volume>20</volume><elocation-id>77</elocation-id><pub-id pub-id-type="doi">10.1007/s11906-018-0880-0</pub-id><pub-id pub-id-type="pmid">29992362</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lengyel</surname> <given-names>E</given-names></name><name><surname>Makowski</surname> <given-names>L</given-names></name><name><surname>DiGiovanni</surname> <given-names>J</given-names></name><name><surname>Kolonin</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cancer as a matter of fat: the crosstalk between adipose tissue and tumors</article-title><source>Trends in Cancer</source><volume>4</volume><fpage>374</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1016/j.trecan.2018.03.004</pub-id><pub-id pub-id-type="pmid">29709261</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Listenberger</surname> <given-names>LL</given-names></name><name><surname>Han</surname> <given-names>X</given-names></name><name><surname>Lewis</surname> <given-names>SE</given-names></name><name><surname>Cases</surname> <given-names>S</given-names></name><name><surname>Farese</surname> <given-names>RV</given-names></name><name><surname>Ory</surname> <given-names>DS</given-names></name><name><surname>Schaffer</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Triglyceride accumulation protects against fatty acid-induced lipotoxicity</article-title><source>PNAS</source><volume>100</volume><fpage>3077</fpage><lpage>3082</lpage><pub-id pub-id-type="doi">10.1073/pnas.0630588100</pub-id><pub-id pub-id-type="pmid">12629214</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Litosch</surname> <given-names>I</given-names></name><name><surname>Hudson</surname> <given-names>TH</given-names></name><name><surname>Mills</surname> <given-names>I</given-names></name><name><surname>Li</surname> <given-names>SY</given-names></name><name><surname>Fain</surname> <given-names>JN</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Forskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytes</article-title><source>Molecular Pharmacology</source><volume>22</volume><fpage>109</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">6289066</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Ge</surname> <given-names>Q</given-names></name><name><surname>Ding</surname> <given-names>M</given-names></name><name><surname>Huang</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A lipid droplet-associated GFP reporter-based screen identifies new fat storage regulators in <italic>C. elegans</italic></article-title><source>Journal of Genetics and Genomics</source><volume>41</volume><fpage>305</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1016/j.jgg.2014.03.002</pub-id><pub-id pub-id-type="pmid">24894357</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>L</given-names></name><name><surname>Zhang</surname> <given-names>K</given-names></name><name><surname>Sandoval</surname> <given-names>H</given-names></name><name><surname>Yamamoto</surname> <given-names>S</given-names></name><name><surname>Jaiswal</surname> <given-names>M</given-names></name><name><surname>Sanz</surname> <given-names>E</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Hui</surname> <given-names>J</given-names></name><name><surname>Graham</surname> <given-names>BH</given-names></name><name><surname>Quintana</surname> <given-names>A</given-names></name><name><surname>Bellen</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration</article-title><source>Cell</source><volume>160</volume><fpage>177</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.12.019</pub-id><pub-id pub-id-type="pmid">25594180</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>L</given-names></name><name><surname>MacKenzie</surname> <given-names>KR</given-names></name><name><surname>Putluri</surname> <given-names>N</given-names></name><name><surname>Maletić-Savatić</surname> <given-names>M</given-names></name><name><surname>Bellen</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The Glia-Neuron lactate shuttle and elevated ROS promote lipid synthesis in neurons and lipid droplet accumulation in Glia via APOE/D</article-title><source>Cell Metabolism</source><volume>26</volume><fpage>719</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.08.024</pub-id><pub-id pub-id-type="pmid">28965825</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longo</surname> <given-names>VD</given-names></name><name><surname>Mattson</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Fasting: molecular mechanisms and clinical applications</article-title><source>Cell Metabolism</source><volume>19</volume><fpage>181</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2013.12.008</pub-id><pub-id pub-id-type="pmid">24440038</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname> <given-names>N</given-names></name><name><surname>Schweiger</surname> <given-names>M</given-names></name><name><surname>Romauch</surname> <given-names>M</given-names></name><name><surname>Grabner</surname> <given-names>GF</given-names></name><name><surname>Eichmann</surname> <given-names>TO</given-names></name><name><surname>Fuchs</surname> <given-names>E</given-names></name><name><surname>Ivkovic</surname> <given-names>J</given-names></name><name><surname>Heier</surname> <given-names>C</given-names></name><name><surname>Mrak</surname> <given-names>I</given-names></name><name><surname>Lass</surname> <given-names>A</given-names></name><name><surname>Höfler</surname> <given-names>G</given-names></name><name><surname>Fledelius</surname> <given-names>C</given-names></name><name><surname>Zechner</surname> <given-names>R</given-names></name><name><surname>Zimmermann</surname> <given-names>R</given-names></name><name><surname>Breinbauer</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Development of small-molecule inhibitors targeting adipose triglyceride lipase</article-title><source>Nature Chemical Biology</source><volume>9</volume><fpage>785</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1038/nchembio.1359</pub-id><pub-id pub-id-type="pmid">24096302</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minchin</surname> <given-names>JEN</given-names></name><name><surname>Scahill</surname> <given-names>CM</given-names></name><name><surname>Staudt</surname> <given-names>N</given-names></name><name><surname>Busch-Nentwich</surname> <given-names>EM</given-names></name><name><surname>Rawls</surname> <given-names>JF</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Deep phenotyping in zebrafish reveals genetic and diet-induced adiposity changes that may inform disease risk</article-title><source>Journal of Lipid Research</source><volume>59</volume><fpage>1536</fpage><lpage>1545</lpage><pub-id pub-id-type="doi">10.1194/jlr.D084525</pub-id><pub-id pub-id-type="pmid">29794036</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minchin</surname> <given-names>JEN</given-names></name><name><surname>Rawls</surname> <given-names>JF</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>A classification system for zebrafish adipose tissues</article-title><source>Disease Models &amp; Mechanisms</source><volume>10</volume><fpage>797</fpage><lpage>809</lpage><pub-id pub-id-type="doi">10.1242/dmm.025759</pub-id><pub-id pub-id-type="pmid">28348140</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minchin</surname> <given-names>JE</given-names></name><name><surname>Rawls</surname> <given-names>JF</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>In vivo imaging and quantification of regional adiposity in zebrafish</article-title><source>Methods in Cell Biology</source><volume>138</volume><fpage>3</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/bs.mcb.2016.11.010</pub-id><pub-id pub-id-type="pmid">28129849</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyanari</surname> <given-names>Y</given-names></name><name><surname>Atsuzawa</surname> <given-names>K</given-names></name><name><surname>Usuda</surname> <given-names>N</given-names></name><name><surname>Watashi</surname> <given-names>K</given-names></name><name><surname>Hishiki</surname> <given-names>T</given-names></name><name><surname>Zayas</surname> <given-names>M</given-names></name><name><surname>Bartenschlager</surname> <given-names>R</given-names></name><name><surname>Wakita</surname> <given-names>T</given-names></name><name><surname>Hijikata</surname> <given-names>M</given-names></name><name><surname>Shimotohno</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The lipid droplet is an important organelle for hepatitis C virus production</article-title><source>Nature Cell Biology</source><volume>9</volume><fpage>1089</fpage><lpage>1097</lpage><pub-id pub-id-type="doi">10.1038/ncb1631</pub-id><pub-id pub-id-type="pmid">17721513</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nath</surname> <given-names>N</given-names></name><name><surname>Chattopadhyay</surname> <given-names>M</given-names></name><name><surname>Pospishil</surname> <given-names>L</given-names></name><name><surname>Cieciura</surname> <given-names>LZ</given-names></name><name><surname>Goswami</surname> <given-names>S</given-names></name><name><surname>Kodela</surname> <given-names>R</given-names></name><name><surname>Saavedra</surname> <given-names>JE</given-names></name><name><surname>Keefer</surname> <given-names>LK</given-names></name><name><surname>Kashfi</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>JS-K, a nitric oxide-releasing prodrug, modulates ß-catenin/TCF signaling in leukemic jurkat cells: evidence of an S-nitrosylated mechanism</article-title><source>Biochemical Pharmacology</source><volume>80</volume><fpage>1641</fpage><lpage>1649</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2010.08.011</pub-id><pub-id pub-id-type="pmid">20797387</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>TB</given-names></name><name><surname>Louie</surname> <given-names>SM</given-names></name><name><surname>Daniele</surname> <given-names>JR</given-names></name><name><surname>Tran</surname> <given-names>Q</given-names></name><name><surname>Dillin</surname> <given-names>A</given-names></name><name><surname>Zoncu</surname> <given-names>R</given-names></name><name><surname>Nomura</surname> <given-names>DK</given-names></name><name><surname>Olzmann</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>DGAT1-Dependent lipid droplet biogenesis protects mitochondrial function during Starvation-Induced autophagy</article-title><source>Developmental Cell</source><volume>42</volume><fpage>9</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2017.06.003</pub-id><pub-id pub-id-type="pmid">28697336</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieman</surname> <given-names>KM</given-names></name><name><surname>Kenny</surname> <given-names>HA</given-names></name><name><surname>Penicka</surname> <given-names>CV</given-names></name><name><surname>Ladanyi</surname> <given-names>A</given-names></name><name><surname>Buell-Gutbrod</surname> <given-names>R</given-names></name><name><surname>Zillhardt</surname> <given-names>MR</given-names></name><name><surname>Romero</surname> <given-names>IL</given-names></name><name><surname>Carey</surname> <given-names>MS</given-names></name><name><surname>Mills</surname> <given-names>GB</given-names></name><name><surname>Hotamisligil</surname> <given-names>GS</given-names></name><name><surname>Yamada</surname> <given-names>SD</given-names></name><name><surname>Peter</surname> <given-names>ME</given-names></name><name><surname>Gwin</surname> <given-names>K</given-names></name><name><surname>Lengyel</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Adipocytes promote ovarian Cancer metastasis and provide energy for rapid tumor growth</article-title><source>Nature Medicine</source><volume>17</volume><fpage>1498</fpage><lpage>1503</lpage><pub-id pub-id-type="doi">10.1038/nm.2492</pub-id><pub-id pub-id-type="pmid">22037646</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oka</surname> <given-names>T</given-names></name><name><surname>Nishimura</surname> <given-names>Y</given-names></name><name><surname>Zang</surname> <given-names>L</given-names></name><name><surname>Hirano</surname> <given-names>M</given-names></name><name><surname>Shimada</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Umemoto</surname> <given-names>N</given-names></name><name><surname>Kuroyanagi</surname> <given-names>J</given-names></name><name><surname>Nishimura</surname> <given-names>N</given-names></name><name><surname>Tanaka</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity</article-title><source>BMC Physiology</source><volume>10</volume><elocation-id>21</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6793-10-21</pub-id><pub-id pub-id-type="pmid">20961460</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olzmann</surname> <given-names>JA</given-names></name><name><surname>Carvalho</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dynamics and functions of lipid droplets</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>20</volume><fpage>137</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1038/s41580-018-0085-z</pub-id><pub-id pub-id-type="pmid">30523332</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otis</surname> <given-names>JP</given-names></name><name><surname>Farber</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>High-fat Feeding paradigm for larval zebrafish: feeding, live imaging, and quantification of food intake</article-title><source>Journal of Visualized Experiments</source><volume>1</volume><elocation-id>54735</elocation-id><pub-id pub-id-type="doi">10.3791/54735</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paar</surname> <given-names>M</given-names></name><name><surname>Jüngst</surname> <given-names>C</given-names></name><name><surname>Steiner</surname> <given-names>NA</given-names></name><name><surname>Magnes</surname> <given-names>C</given-names></name><name><surname>Sinner</surname> <given-names>F</given-names></name><name><surname>Kolb</surname> <given-names>D</given-names></name><name><surname>Lass</surname> <given-names>A</given-names></name><name><surname>Zimmermann</surname> <given-names>R</given-names></name><name><surname>Zumbusch</surname> <given-names>A</given-names></name><name><surname>Kohlwein</surname> <given-names>SD</given-names></name><name><surname>Wolinski</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Remodeling of lipid droplets during lipolysis and growth in adipocytes</article-title><source>Journal of Biological Chemistry</source><volume>287</volume><fpage>11164</fpage><lpage>11173</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.316794</pub-id><pub-id pub-id-type="pmid">22311986</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parichy</surname> <given-names>DM</given-names></name><name><surname>Elizondo</surname> <given-names>MR</given-names></name><name><surname>Mills</surname> <given-names>MG</given-names></name><name><surname>Gordon</surname> <given-names>TN</given-names></name><name><surname>Engeszer</surname> <given-names>RE</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Normal table of postembryonic zebrafish development: staging by externally visible anatomy of the living fish</article-title><source>Developmental Dynamics</source><volume>238</volume><fpage>2975</fpage><lpage>3015</lpage><pub-id pub-id-type="doi">10.1002/dvdy.22113</pub-id><pub-id pub-id-type="pmid">19891001</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rambold</surname> <given-names>AS</given-names></name><name><surname>Cohen</surname> <given-names>S</given-names></name><name><surname>Lippincott-Schwartz</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Fatty acid trafficking in starved cells: regulation by lipid droplet lipolysis, autophagy, and mitochondrial fusion dynamics</article-title><source>Developmental Cell</source><volume>32</volume><fpage>678</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2015.01.029</pub-id><pub-id pub-id-type="pmid">25752962</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawada</surname> <given-names>T</given-names></name><name><surname>Miyoshi</surname> <given-names>H</given-names></name><name><surname>Shimada</surname> <given-names>K</given-names></name><name><surname>Suzuki</surname> <given-names>A</given-names></name><name><surname>Okamatsu-Ogura</surname> <given-names>Y</given-names></name><name><surname>Perfield</surname> <given-names>JW</given-names></name><name><surname>Kondo</surname> <given-names>T</given-names></name><name><surname>Nagai</surname> <given-names>S</given-names></name><name><surname>Shimizu</surname> <given-names>C</given-names></name><name><surname>Yoshioka</surname> <given-names>N</given-names></name><name><surname>Greenberg</surname> <given-names>AS</given-names></name><name><surname>Kimura</surname> <given-names>K</given-names></name><name><surname>Koike</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Perilipin overexpression in white adipose tissue induces a Brown fat-like phenotype</article-title><source>PLOS ONE</source><volume>5</volume><elocation-id>e14006</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0014006</pub-id><pub-id pub-id-type="pmid">21103377</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname> <given-names>J</given-names></name><name><surname>Arganda-Carreras</surname> <given-names>I</given-names></name><name><surname>Frise</surname> <given-names>E</given-names></name><name><surname>Kaynig</surname> <given-names>V</given-names></name><name><surname>Longair</surname> <given-names>M</given-names></name><name><surname>Pietzsch</surname> <given-names>T</given-names></name><name><surname>Preibisch</surname> <given-names>S</given-names></name><name><surname>Rueden</surname> <given-names>C</given-names></name><name><surname>Saalfeld</surname> <given-names>S</given-names></name><name><surname>Schmid</surname> <given-names>B</given-names></name><name><surname>Tinevez</surname> <given-names>JY</given-names></name><name><surname>White</surname> <given-names>DJ</given-names></name><name><surname>Hartenstein</surname> <given-names>V</given-names></name><name><surname>Eliceiri</surname> <given-names>K</given-names></name><name><surname>Tomancak</surname> <given-names>P</given-names></name><name><surname>Cardona</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schweiger</surname> <given-names>M</given-names></name><name><surname>Romauch</surname> <given-names>M</given-names></name><name><surname>Schreiber</surname> <given-names>R</given-names></name><name><surname>Grabner</surname> <given-names>GF</given-names></name><name><surname>Hütter</surname> <given-names>S</given-names></name><name><surname>Kotzbeck</surname> <given-names>P</given-names></name><name><surname>Benedikt</surname> <given-names>P</given-names></name><name><surname>Eichmann</surname> <given-names>TO</given-names></name><name><surname>Yamada</surname> <given-names>S</given-names></name><name><surname>Knittelfelder</surname> <given-names>O</given-names></name><name><surname>Diwoky</surname> <given-names>C</given-names></name><name><surname>Doler</surname> <given-names>C</given-names></name><name><surname>Mayer</surname> <given-names>N</given-names></name><name><surname>De Cecco</surname> <given-names>W</given-names></name><name><surname>Breinbauer</surname> <given-names>R</given-names></name><name><surname>Zimmermann</surname> <given-names>R</given-names></name><name><surname>Zechner</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>14859</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms14859</pub-id><pub-id pub-id-type="pmid">28327588</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shami</surname> <given-names>PJ</given-names></name><name><surname>Saavedra</surname> <given-names>JE</given-names></name><name><surname>Wang</surname> <given-names>LY</given-names></name><name><surname>Bonifant</surname> <given-names>CL</given-names></name><name><surname>Diwan</surname> <given-names>BA</given-names></name><name><surname>Singh</surname> <given-names>SV</given-names></name><name><surname>Gu</surname> <given-names>Y</given-names></name><name><surname>Fox</surname> <given-names>SD</given-names></name><name><surname>Buzard</surname> <given-names>GS</given-names></name><name><surname>Citro</surname> <given-names>ML</given-names></name><name><surname>Waterhouse</surname> <given-names>DJ</given-names></name><name><surname>Davies</surname> <given-names>KM</given-names></name><name><surname>Ji</surname> <given-names>X</given-names></name><name><surname>Keefer</surname> <given-names>LK</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>JS-K, a Glutathione/Glutathione S-Transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity</article-title><source>Molecular Cancer Therapeutics</source><volume>2</volume><fpage>409</fpage><lpage>417</lpage><pub-id pub-id-type="pmid">12700285</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamler</surname> <given-names>JS</given-names></name><name><surname>Lamas</surname> <given-names>S</given-names></name><name><surname>Fang</surname> <given-names>FC</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Nitrosylation. the prototypic redox-based signaling mechanism</article-title><source>Cell</source><volume>106</volume><fpage>675</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(01)00495-0</pub-id><pub-id pub-id-type="pmid">11572774</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname> <given-names>HN</given-names></name><name><surname>Tang</surname> <given-names>CY</given-names></name><name><surname>Man</surname> <given-names>XF</given-names></name><name><surname>Tan</surname> <given-names>SW</given-names></name><name><surname>Guo</surname> <given-names>Y</given-names></name><name><surname>Tang</surname> <given-names>J</given-names></name><name><surname>Zhou</surname> <given-names>CL</given-names></name><name><surname>Zhou</surname> <given-names>HD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Plasticity of adipose tissue in response to fasting and refeeding in male mice</article-title><source>Nutrition &amp; Metabolism</source><volume>14</volume><elocation-id>3</elocation-id><pub-id pub-id-type="doi">10.1186/s12986-016-0159-x</pub-id><pub-id pub-id-type="pmid">28070205</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Targett-Adams</surname> <given-names>P</given-names></name><name><surname>Chambers</surname> <given-names>D</given-names></name><name><surname>Gledhill</surname> <given-names>S</given-names></name><name><surname>Hope</surname> <given-names>RG</given-names></name><name><surname>Coy</surname> <given-names>JF</given-names></name><name><surname>Girod</surname> <given-names>A</given-names></name><name><surname>McLauchlan</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Live cell analysis and targeting of the lipid droplet-binding adipocyte differentiation-related protein</article-title><source>Journal of Biological Chemistry</source><volume>278</volume><fpage>15998</fpage><lpage>16007</lpage><pub-id pub-id-type="doi">10.1074/jbc.M211289200</pub-id><pub-id pub-id-type="pmid">12591929</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tauchi-Sato</surname> <given-names>K</given-names></name><name><surname>Ozeki</surname> <given-names>S</given-names></name><name><surname>Houjou</surname> <given-names>T</given-names></name><name><surname>Taguchi</surname> <given-names>R</given-names></name><name><surname>Fujimoto</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The surface of lipid droplets is a phospholipid monolayer with a unique fatty acid composition</article-title><source>Journal of Biological Chemistry</source><volume>277</volume><fpage>44507</fpage><lpage>44512</lpage><pub-id pub-id-type="doi">10.1074/jbc.M207712200</pub-id><pub-id pub-id-type="pmid">12221100</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tchernof</surname> <given-names>A</given-names></name><name><surname>Després</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Pathophysiology of human visceral obesity: an update</article-title><source>Physiological Reviews</source><volume>93</volume><fpage>359</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1152/physrev.00033.2011</pub-id><pub-id pub-id-type="pmid">23303913</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velázquez</surname> <given-names>AP</given-names></name><name><surname>Tatsuta</surname> <given-names>T</given-names></name><name><surname>Ghillebert</surname> <given-names>R</given-names></name><name><surname>Drescher</surname> <given-names>I</given-names></name><name><surname>Graef</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Lipid droplet-mediated ER homeostasis regulates autophagy and cell survival during starvation</article-title><source>Journal of Cell Biology</source><volume>212</volume><fpage>621</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1083/jcb.201508102</pub-id><pub-id pub-id-type="pmid">26953354</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verboven</surname> <given-names>K</given-names></name><name><surname>Wouters</surname> <given-names>K</given-names></name><name><surname>Gaens</surname> <given-names>K</given-names></name><name><surname>Hansen</surname> <given-names>D</given-names></name><name><surname>Bijnen</surname> <given-names>M</given-names></name><name><surname>Wetzels</surname> <given-names>S</given-names></name><name><surname>Stehouwer</surname> <given-names>CD</given-names></name><name><surname>Goossens</surname> <given-names>GH</given-names></name><name><surname>Schalkwijk</surname> <given-names>CG</given-names></name><name><surname>Blaak</surname> <given-names>EE</given-names></name><name><surname>Jocken</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>4677</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-22962-x</pub-id><pub-id pub-id-type="pmid">29549282</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vevea</surname> <given-names>JD</given-names></name><name><surname>Garcia</surname> <given-names>EJ</given-names></name><name><surname>Chan</surname> <given-names>RB</given-names></name><name><surname>Zhou</surname> <given-names>B</given-names></name><name><surname>Schultz</surname> <given-names>M</given-names></name><name><surname>Di Paolo</surname> <given-names>G</given-names></name><name><surname>McCaffery</surname> <given-names>JM</given-names></name><name><surname>Pon</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Role for lipid droplet biogenesis and microlipophagy in adaptation to lipid imbalance in yeast</article-title><source>Developmental Cell</source><volume>35</volume><fpage>584</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2015.11.010</pub-id><pub-id pub-id-type="pmid">26651293</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieyres</surname> <given-names>G</given-names></name><name><surname>Reichert</surname> <given-names>I</given-names></name><name><surname>Carpentier</surname> <given-names>A</given-names></name><name><surname>Vondran</surname> <given-names>FWR</given-names></name><name><surname>Pietschmann</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The ATGL lipase cooperates with ABHD5 to mobilize lipids for hepatitis C virus assembly</article-title><source>PLOS Pathogens</source><volume>16</volume><elocation-id>e1008554</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1008554</pub-id><pub-id pub-id-type="pmid">32542055</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Quiroga</surname> <given-names>AD</given-names></name><name><surname>Lehner</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Analysis of lipid droplets in hepatocytes</article-title><source>Methods in Cell Biology</source><volume>116</volume><fpage>107</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-408051-5.00007-3</pub-id><pub-id pub-id-type="pmid">24099290</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname> <given-names>RM</given-names></name><name><surname>Sessa</surname> <given-names>A</given-names></name><name><surname>Burke</surname> <given-names>C</given-names></name><name><surname>Bowman</surname> <given-names>T</given-names></name><name><surname>LeBlanc</surname> <given-names>J</given-names></name><name><surname>Ceol</surname> <given-names>C</given-names></name><name><surname>Bourque</surname> <given-names>C</given-names></name><name><surname>Dovey</surname> <given-names>M</given-names></name><name><surname>Goessling</surname> <given-names>W</given-names></name><name><surname>Burns</surname> <given-names>CE</given-names></name><name><surname>Zon</surname> <given-names>LI</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Transparent adult zebrafish as a tool for in vivo transplantation analysis</article-title><source>Cell Stem Cell</source><volume>2</volume><fpage>183</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2007.11.002</pub-id><pub-id pub-id-type="pmid">18371439</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilfling</surname> <given-names>F</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Haas</surname> <given-names>JT</given-names></name><name><surname>Krahmer</surname> <given-names>N</given-names></name><name><surname>Gould</surname> <given-names>TJ</given-names></name><name><surname>Uchida</surname> <given-names>A</given-names></name><name><surname>Cheng</surname> <given-names>JX</given-names></name><name><surname>Graham</surname> <given-names>M</given-names></name><name><surname>Christiano</surname> <given-names>R</given-names></name><name><surname>Fröhlich</surname> <given-names>F</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Buhman</surname> <given-names>KK</given-names></name><name><surname>Coleman</surname> <given-names>RA</given-names></name><name><surname>Bewersdorf</surname> <given-names>J</given-names></name><name><surname>Farese</surname> <given-names>RV</given-names></name><name><surname>Walther</surname> <given-names>TC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Triacylglycerol synthesis enzymes mediate lipid droplet growth by relocalizing from the ER to lipid droplets</article-title><source>Developmental Cell</source><volume>24</volume><fpage>384</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2013.01.013</pub-id><pub-id pub-id-type="pmid">23415954</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Wilson</surname> <given-names>MH</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name><name><surname>Farber</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Imaging cytoplasmic lipid droplets in vivo; with fluorescent perilipin 2 and perilipin 3 knockin zebrafish</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2021.01.10.426109</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname> <given-names>Y</given-names></name><name><surname>Lim</surname> <given-names>S</given-names></name><name><surname>Bråkenhielm</surname> <given-names>E</given-names></name><name><surname>Cao</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Adipose angiogenesis: quantitative methods to study microvessel growth, regression and remodeling in vivo</article-title><source>Nature Protocols</source><volume>5</volume><fpage>912</fpage><lpage>920</lpage><pub-id pub-id-type="doi">10.1038/nprot.2010.46</pub-id><pub-id pub-id-type="pmid">20431536</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname> <given-names>Y</given-names></name><name><surname>Eto</surname> <given-names>M</given-names></name><name><surname>Ito</surname> <given-names>Y</given-names></name><name><surname>Mochizuki</surname> <given-names>S</given-names></name><name><surname>Son</surname> <given-names>BK</given-names></name><name><surname>Ogawa</surname> <given-names>S</given-names></name><name><surname>Iijima</surname> <given-names>K</given-names></name><name><surname>Kaneki</surname> <given-names>M</given-names></name><name><surname>Kozaki</surname> <given-names>K</given-names></name><name><surname>Toba</surname> <given-names>K</given-names></name><name><surname>Akishita</surname> <given-names>M</given-names></name><name><surname>Ouchi</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Suppressive role of PPARγ-Regulated endothelial nitric oxide synthase in adipocyte lipolysis</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0136597</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0136597</pub-id><pub-id pub-id-type="pmid">26317347</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zebisch</surname> <given-names>K</given-names></name><name><surname>Voigt</surname> <given-names>V</given-names></name><name><surname>Wabitsch</surname> <given-names>M</given-names></name><name><surname>Brandsch</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Protocol for effective differentiation of 3T3-L1 cells to adipocytes</article-title><source>Analytical Biochemistry</source><volume>425</volume><fpage>88</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.ab.2012.03.005</pub-id><pub-id pub-id-type="pmid">22425542</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>M</given-names></name><name><surname>Di Martino</surname> <given-names>JS</given-names></name><name><surname>Bowman</surname> <given-names>RL</given-names></name><name><surname>Campbell</surname> <given-names>NR</given-names></name><name><surname>Baksh</surname> <given-names>SC</given-names></name><name><surname>Simon-Vermot</surname> <given-names>T</given-names></name><name><surname>Kim</surname> <given-names>IS</given-names></name><name><surname>Haldeman</surname> <given-names>P</given-names></name><name><surname>Mondal</surname> <given-names>C</given-names></name><name><surname>Yong-Gonzales</surname> <given-names>V</given-names></name><name><surname>Abu-Akeel</surname> <given-names>M</given-names></name><name><surname>Merghoub</surname> <given-names>T</given-names></name><name><surname>Jones</surname> <given-names>DR</given-names></name><name><surname>Zhu</surname> <given-names>XG</given-names></name><name><surname>Arora</surname> <given-names>A</given-names></name><name><surname>Ariyan</surname> <given-names>CE</given-names></name><name><surname>Birsoy</surname> <given-names>K</given-names></name><name><surname>Wolchok</surname> <given-names>JD</given-names></name><name><surname>Panageas</surname> <given-names>KS</given-names></name><name><surname>Hollmann</surname> <given-names>T</given-names></name><name><surname>Bravo-Cordero</surname> <given-names>JJ</given-names></name><name><surname>White</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Adipocyte-Derived lipids mediate melanoma progression via FATP proteins</article-title><source>Cancer Discovery</source><volume>8</volume><fpage>1006</fpage><lpage>1025</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-17-1371</pub-id><pub-id pub-id-type="pmid">29903879</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmermann</surname> <given-names>R</given-names></name><name><surname>Strauss</surname> <given-names>JG</given-names></name><name><surname>Haemmerle</surname> <given-names>G</given-names></name><name><surname>Schoiswohl</surname> <given-names>G</given-names></name><name><surname>Birner-Gruenberger</surname> <given-names>R</given-names></name><name><surname>Riederer</surname> <given-names>M</given-names></name><name><surname>Lass</surname> <given-names>A</given-names></name><name><surname>Neuberger</surname> <given-names>G</given-names></name><name><surname>Eisenhaber</surname> <given-names>F</given-names></name><name><surname>Hermetter</surname> <given-names>A</given-names></name><name><surname>Zechner</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase</article-title><source>Science</source><volume>306</volume><fpage>1383</fpage><lpage>1386</lpage><pub-id pub-id-type="doi">10.1126/science.1100747</pub-id><pub-id pub-id-type="pmid">15550674</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.64744.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Schlegel</surname><given-names>Amnon</given-names></name><role>Reviewing Editor</role><aff><institution>University of Utah School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Schlegel</surname><given-names>Amnon</given-names> </name><role>Reviewer</role><aff><institution>University of Utah School of Medicine</institution><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Minchin</surname><given-names>James</given-names> </name><role>Reviewer</role><aff><institution/></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>In this rigorously revised manuscript you and your colleagues show that your Pin2-tdTomato fusion protein system (in whole zebrafish and in melanoma cells) is a robust reporter of lipid mass. The carefully controlled time series, high-fat feeding, and dose-response experiments strengthen your conclusions. Your reporter line will be a major resource to those in the lipid droplet field. The explicit statements regarding transgenic line and source code availability are major steps in spreading the use of your resource.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;An in vivo reporter for tracking lipid droplet dynamics in transparent zebrafish&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Amnon Schlegel as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Didier Stainier as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: James Minchin (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>As the editors have judged that your manuscript is of interest, but as described below that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is &quot;in revision at <italic>eLife</italic>&quot;. Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)</p><p>In this Tools and Resources manuscript, the authors present a transgenic zebrafish line ubiquitously expressing a lipid droplet coat protein gene fused to a fluorescent protein. The authors characterize the properties of this reporter in labeling adipocyte lipid droplets of optically transparent juveniles and adults casper mutants. Experiments are presented using this reporter construct to validate the results of a chemical screen conducted in in vitro-differentiated adipocytes, revealing a role for nitric oxide signaling in controlling lipolysis. Several hits from this screen are also validated in a zebrafish melanoma cell line system expressing the lipid droplet reporter system. The authors posit transgenic reporter system will be useful to workers interested in lipid droplet accumulation in an intact vertebrate animal.</p><p>The authors prepared a transgenic zebrafish whose official name should be stated as Tg-3.5ubb:plin2-tdTomato throughout the manuscript. This line expresses a fusion protein of the lipid droplet coat protein Perilipin 2 with a C-terminally fused tdTomato fluorescent reporter (Figure 1). This line was prepared to establish a system for evaluating lipid droplets in an intact vertebrate model organism, something not available to the research community prior to this study. The authors posit this tool will be of use to other researchers interested in studying lipid droplet biology with implications for several diseases.</p><p>The authors use the reporter line to examine the appearance of lipid droplet area in the visceral depots of late larvae (Figure 2); monitor the decrease lipid droplet area in starvation and following adrenergic signaling-driven lipolytic states (figure 3); and to demonstrate an increase in adipose area in a high-fat dietary challenge (Figure 4).</p><p>The authors then conducted a chemical screen in 3T3-L1 differentiated adipocytes for compounds that modulate lipolysis (glycerol release being the high-throughput assay read-out). They find multiple nitric oxide modulators inhibit lipolysis, and demonstrate that treatment of fasted Tg-3.5ubb:plin2-tdTomato juveniles with the hit compounds also modulates lipid droplet area. These same compounds also modulate lipid droplet number and size in a zebrafish melanoma cell line.</p><p>The three reviewers agree that the manuscript represents a potentially major advance. For labs using zebrafish, this tool will provide new abilities to monitor lipid droplets and their potential roles in metabolic challenges and diseases like cancer. This reporter could also allow for novel understanding of heterogeneity of adipocytes and lipid droplets by allowing study of how single cells and even single lipid droplets dynamically change in an organism. The essential revisions were formulated after discussion in the hopes of strengthening the manuscript and yielding a tool of wide interest to the field.</p><p>Title:</p><p>See the comments below regarding the need to include the chemical screen in the title or abstract.</p><p>Essential revisions:</p><p>1. A fuller ontogeny of lipid droplets within adipocytes should be feasible with the authors new reporter: starting from feeding (5 to 7 dfp) , a time series of representative larval whole-mount photomicrographs should be presented to demonstrate when, where, and to what extent the reporter begins to report. (Figure 1). Others have used a similar lipid droplet coat protein labeling approach in cell culture models and invertebrates; these citations are more pertinent than several review articles (https://pubmed.ncbi.nlm.nih.gov/12591929/) and (https://pubmed.ncbi.nlm.nih.gov/24894357/). An alternative, probe-free, whole animal imaging platform has been described in zebrafish, and merits discussion: https://pubmed.ncbi.nlm.nih.gov/33268772/.</p><p>2. A direct comparison of the tdTomato signal with a fluorescent lipid dye such as BODIPY 493/503 in a time series would allow the reader to grasp what the advantages and disadvantages of both approaches are. A critical control for this experiment is to use analyze the fluorescent lipid signal of casper siblings not carrying the transgene to assess whether the transgene itself alters lipid accumulation. The presence of a Perilipin A transgene in mouse adipose alters whole body physiology, making the need to evaluate the zebrafish Plin2-tdTomato transgenic for possible neomorphic phenotypes critical: https://pubmed.ncbi.nlm.nih.gov/21103377/. Along similar lines, the text from lines 17 to 58 and line 75 should be revised to more fairly describe the body of work using several lipid dyes in this model system.</p><p>3. A prolonged fast is feasible, and has been done with fluorescent lipid molecule vital stains (again, see point 1 regarding the robust read-out available with these probes and the need for balanced discussion of their limitations). Conducting such a fast would greatly enhance the results of Figure 2. A time course of up to 7 days would be very informative, revealing how the tdTomato signal decreases as lipid mass decreases. This would also reveal how a transgene under a ubiquitous promoter responds to loss of a cellular structure. This point mirrors the first: casper animals lacking the transgene should be examined with concurrent BODIPY staining, since this would reveal if the transgene's presence alters the kinetics of lipolysis. If single animals could be tracked, that would also enhance the power of the tool to reveal individual organism lipid levels. Of course, repeated microscopic mounting might not be feasible; but sufficient animals will survive the process to make initial and final data points informative (Figure 2).</p><p>4. The impact of the short-term (7 days) feeding of the &quot;HFD&quot; on mass and condition factor should be presented. The expansion of visceral lipid area seems rather modest in 7 days; doubling this duration and plotting time series for the changes in SL, mass, and adipose fluorescent area would reveal the dynamic range of this tool in revealing increases in adiposity. A second diet of age-appropriate live feed would also make the results more useful to other workers: the defined diet the authors present might not be widely used by others.</p><p>5. The scale and scope of the chemical screen should be described in the title, abstract, or both. The potent ATGL inhibitor Atglistatin has a much larger effect in preventing loss of fluorescent area in a 24-hour drug treatment in vivo than the nitric oxide donor JS-K or the thioredoxin reductase inhibitor does. This might reflect dose more than potency of mechanism: 40 μm vs. 1 uM. A dose range for the nitric oxide modulators is needed to make valid comparisons and to address the power of the transgenic system to serve as a valid readout in future chemical screens (i.e., using these animals and not 3T3L1 cells will reveal both autonomous and non-autonomous mechanisms of adipose lipid accumulation). Others have made a similar observation that merits citation: https://pubmed.ncbi.nlm.nih.gov/26317347/.</p><p>6. Paralleling points 1 to 3, the melanoma cell experiments should be done with the BODIPY tracer as a comparator to reveal what is gained with the transgenic reporter. A video of melanoma cells does not add much to this manuscript, since it is the power of the in vivo reporter that is being showcased and could be demonstrated better with addressing the above points.</p><p>7. Data Availability</p><p>The availability of the Tg(-3.5ubb:plin2-tdTomato) casper line is not disclosed, while a competing interest of the senior author's use of the casper line is. Given the NIH funding listed, this model organism should be deposited in the Zebrafish International Resource Center, and a statement regarding this should be included in the manuscript.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.64744.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1. A fuller ontogeny of lipid droplets within adipocytes should be feasible with the authors new reporter: starting from feeding (5 to 7 dfp) , a time series of representative larval whole mount photomicrographs should be presented to demonstrate when, where, and to what extent the reporter begins to report. (Figure 1). Others have used a similar lipid droplet coat protein labeling approach in cell culture models and invertebrates; these citations are more pertinent than several review articles (https://pubmed.ncbi.nlm.nih.gov/12591929/) and (https://pubmed.ncbi.nlm.nih.gov/24894357/). An alternative, probe-free, whole animal imaging platform has been described in zebrafish, and merits discussion: https://pubmed.ncbi.nlm.nih.gov/33268772/.</p></disp-quote><p>We have performed a time-series analysis of expression in both WT siblings as well as the <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> line. This was done at 5, 14, 21, 42dpf and adulthood. In addition, and in response to point #2 below, we simultaneously stained with BODIPY to be able to compare our transgenic with a more established lipid dye. Using previously developed nomenclature for various adipocyte depots in zebrafish (Minchin and Rawls, 2017a), we created heatmaps of expression for both BODIPY and tdTomato (Supplementary Figure 2A) and show representative images (Supplementary Figure 2B). These results demonstrate that the transgenic reporter is first visible at 14dpf, which matches what is seen by BODIPY at this time point. Expression in the transgenic line increases with time, as expected and includes additional depots by adulthood, again matching closely what is seen in the BODIPY stained animals.</p><p>We agree with the comment that citation of primary literature, rather than review papers, is appropriate. We have corrected this in the text.</p><disp-quote content-type="editor-comment"><p>2. A direct comparison of the tdTomato signal with a fluorescent lipid dye such as BODIPY 493/503 in a time series would allow the reader to grasp what the advantages and disadvantages of both approaches are. A critical control for this experiment is to use analyze the fluorescent lipid signal of casper siblings not carrying the transgene to assess whether the transgene itself alters lipid accumulation. The presence of a Perilipin A transgene in mouse adipose alters whole body physiology, making the need to evaluate the zebrafish Plin2-tdTomato transgenic for possible neomorphic phenotypes critical: https://pubmed.ncbi.nlm.nih.gov/21103377/. Along similar lines, the text from lines 17 to 58 and line 75 should be revised to more fairly describe the body of work using several lipid dyes in this model system.</p></disp-quote><p>We agree that the use of sibling controls, along with BODIPY, was an essential experiment to rule out a neomorphic effect of the transgene. As noted in point #1 above, we have performed these experiments and see strong concordance between BODIPY staining and tdTomato fluorescence, with no obvious effect of the transgene.</p><p>Specifically, in Figure 2C-F, we see no significant difference in BODIPY staining between the WT siblings and the <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> line (average BODIPY area: WT = 0.37 ± 0.04 mm<sup>2</sup> and <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> = 0.34 ± 0.05 mm<sup>2</sup> | Mann Whitney test p=0.42). Furthermore, in quantifying the effect across time (see the heatmap in Supplementary Figure 2), we see no difference in the timing of BODIPY staining in WT siblings versus transgenics. We also saw no effect of the transgene on lipolysis during prolonged fasting (see point #3, below). Finally, and as explained in more detail in point #6 below, we also found that the transgene did not affect lipid droplet content in the ZMEL melanoma cell line experiments as well. Thus, while we cannot rule out an effect on the transgene is every single physiologic situation, we do not see an effect during normal development or in the cancer context.</p><p>We have modified the text to take these new results into account and put them into better context with the existing literature regarding lipid dyes.</p><disp-quote content-type="editor-comment"><p>3. A prolonged fast is feasible, and has been done with fluorescent lipid molecule vital stains (again, see point 1 regarding the robust read-out available with these probes and the need for balanced discussion of their limitations). Conducting such a fast would greatly enhance the results of Figure 2. A time course of up to 7 days would be very informative, revealing how the tdTomato signal decreases as lipid mass decreases. This would also reveal how a transgene under a ubiquitous promoter responds to loss of a cellular structure. This point mirrors the first: casper animals lacking the transgene should be examined with concurrent BODIPY staining, since this would reveal if the transgene's presence alters the kinetics of lipolysis. If single animals could be tracked, that would also enhance the power of the tool to reveal individual organism lipid levels. Of course, repeated microscopic mounting might not be feasible; but sufficient animals will survive the process to make initial and final data points informative (Figure 2).</p></disp-quote><p>We have now performed this experiment as suggested. The new data is now shown in Figure 3 of the revised manuscript. We first performed the control experiment in which we used WT and <italic>Tg(-3.5ubb:plin2-tdTomato)</italic> siblings at 21dpf, and fasted them for 7 days and stained them with BODIPY (to further address point #2 above). Individual animals were tracked within each group, and the data then pooled for each group. We observed a decrease in BODIPY staining to the same extent in the WT or Tg control (Figure 3A-E). We then further quantified the tdTomato signal at days 0, 2, 5, and 7 during a prolonged 7d fast and saw the expected decrease in adipocyte area (Figure 3F-J). These data again suggest that the presence of the transgene does not affect overall lipolysis after fasting, and that the transgene can be used to track lipid droplets over a prolonged period of time.</p><disp-quote content-type="editor-comment"><p>4. The impact of the short-term (7 days) feeding of the &quot;HFD&quot; on mass and condition factor should be presented. The expansion of visceral lipid area seems rather modest in 7 days; doubling this duration and plotting time series for the changes in SL, mass, and adipose fluorescent area would reveal the dynamic range of this tool in revealing increases in adiposity. A second diet of age-appropriate live feed would also make the results more useful to other workers: the defined diet the authors present might not be widely used by others.</p></disp-quote><p>We have performed this experiment in which we fed either a control/standard diet or high-fat diets and measured area and standard length from 0 to 14 days. This revealed that the majority of the increase in adiposity from high-fat diet occurs by day 7, with relatively little further increase by day 14. Surprisingly, we found little acceleration of standard length in this assay, suggesting the effect of HFD is very specific to adipose tissue. These data are shown in Figure 4A-E. We attempted to measure the mass of the fish in addition to SL and fluorescent area but the small SLs and variable adherence of water to the fish produced inconsistent results.</p><p>While we agree that live-feed diets remain common in the field, our facility has converted to a powdered feed diet. In addition, there is no simple way to make a high fat diet addition to a live feed diet. We have repeatedly tried adding egg yolk to the diet (to mimic a high fat diet) and have found that the fish consistently avoid eating it. We did not feel it would be a fair comparison to compare a standard live feed diet to a powdered high fat diet. Thus for these experiments, we used either a standard control diet or high-fat feed diet from Sparos, which mirrors what is increasingly being used in many facilities, including ours.</p><disp-quote content-type="editor-comment"><p>5. The scale and scope of the chemical screen should be described in the title, abstract, or both. The potent ATGL inhibitor Atglistatin has a much larger effect in preventing loss of fluorescent area in a 24-hour drug treatment in vivo than the nitric oxide donor JS-K or the thioredoxin reductase inhibitor does. This might reflect dose more than potency of mechanism: 40 μm vs. 1 uM. A dose range for the nitric oxide modulators is needed to make valid comparisons and to address the power of the transgenic system to serve as a valid readout in future chemical screens (i.e., using these animals and not 3T3L1 cells will reveal both autonomous and non-autonomous mechanisms of adipose lipid accumulation). Others have made a similar observation that merits citation: https://pubmed.ncbi.nlm.nih.gov/26317347/.</p></disp-quote><p>We agree that a more robust dose response curve was needed for the in vivo experiments. We first performed dose-limiting toxicity studies in the fish to find the maximally tolerated dose (MTD) that did not cause death or illness. This was 40µM for Atglistatin, 1µM for Auranofin, and 1µM for JS-K (Supplementary Figure 5A-C). Based on this, we tested these drugs at their MTD in vivo and measured lipid droplet area, and confirmed that only Atglistatin and JS-K had an effect at these doses (Figure 5C-E). Because Atglistatin was very well tolerated at multiple doses, we also measured lipid droplet area after exposure to 1µM, 10µM and 40µM and again found only an effect at the MTD of 40µM (Supplementary Figure 5D-F). These data suggest that for in vivo studies, it is likely that the efficacy of a given drug is likely to be greatest at or near the MTD, which is not surprising given the potential for lipolysis to affect systemic physiology.</p><p>We have modified the abstract to better reflect the chemical screen aspect of the paper, and will add in the additional relevant citation.</p><disp-quote content-type="editor-comment"><p>6. Paralleling points 1 to 3, the melanoma cell experiments should be done with the BODIPY tracer as a comparator to reveal what is gained with the transgenic reporter. A video of melanoma cells does not add much to this manuscript, since it is the power of the in vivo reporter that is being showcased and could be demonstrated better with addressing the above points.</p></disp-quote><p>We have performed this control experiment. Analogous to what we did in the sibling fish (points #1 and #2 above), we exposed either control ZMEL-GFP or ZMEL-LD cells to increasing doses of oleic acid, and stained them with the far-red dye Lipidtox (which fluoresces in a range distinct from either GFP or tdTomato). We then quantified median fluorescence intensity (MFI) for far-red fluorescence (from the Lipidtox). Consistent with our in vivo results, we saw no effect of the transgene on accumulation of Lipidtox staining after oleic acid treatment.</p><p>To further explore this, we then used FACS to quantify the percentage of tdTomato versus Lipidtox positive cells after oleic acid. Instead of measuring MFI in this assay, cells were gated with a negative control population and anything above that control gate is considered positive, as is common in FACS. This was highly informative. While the Lipid staining clearly is responsive to oleic acid, it did not show a very high dynamic range, in that the various concentrations read out in fairly similar ways. In contrast, the same assay using the tdTomato transgene showed very high dynamic range, essentially mirroring the concentration of oleic acid added to the media.</p><p>Taken together, these two experiments demonstrate that the transgene does not exert a neomorphic effect on the melanoma cells, and further demonstrates the potential usefulness of the transgene compared to lipid dyes. A consideration of this data has been added to the manuscript.</p><disp-quote content-type="editor-comment"><p>7. Data Availability</p><p>The availability of the Tg(-3.5ubb:plin2-tdTomato) casper line is not disclosed, while a competing interest of the senior author's use of the casper line is. Given the NIH funding listed, this model organism should be deposited in the Zebrafish International Resource Center, and a statement regarding this should be included in the manuscript.</p></disp-quote><p>These fish will be deposited in ZIRC as is standard in the field. However, in some cases ZIRC will not accept all transgenics, depending on their capacity. Should that be the case, we would readily make the animals available to any lab who requests it. In addition, we will make all transgenes available via Addgene.</p></body></sub-article></article>